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ABSTRACT 
Aim: The overall aim of this thesis was to investigate correlates of physical activity in older 
adults with Parkinson’s disease and to evaluate the effects, both short- and long term, of the 
HiBalance program on physical activity and sedentary. Further, to investigate the associated 
factors of a training effect on physical activity. To this end disease-specific physical activity 
estimates are needed. 
Methods: In Paper 1 accelerometer cut points for different walking speeds were defined. 
Thirty older adults with mild-to-moderate Parkinson’s disease walked at self-defined speeds 
of brisk, normal and slow speeds for three minutes in an indoor corridor. Walking speed was 
used as a reference measure, and cut points were generated using ROC curves. The cut points 
were cross-validated and Cohen´s quadratic weighted Kappa was calculated. In Paper II, 
correlates of both total physical activity and cut point-defined brisk walking were 
investigated by applying correlation analysis followed by multiple linear regression to 
accelerometer data. In Paper III, short- and long-term effects of the HiBalance program on 
physical activity and sedentary behavior were evaluated, using mixed analysis of variance 
and a multilevel model. Further, associated factors to a training effect on physical activity 
were investigated using a multiple linear regression. 
Results: Optimal cut points for the vertical axis were ≤328 and ≥730 counts / 15 seconds for 
walking speeds at ≤1.0 m/s and >1.3 m/s, respectively. Sensitivity ranged between 68-100 %, 
with specificity between 75-82 %, whilst validation and Kappa analysis showed 74% 
absolute agreement and a substantial agreement of κ = 0.79 (95% CI 0.70–0.89), respectively. 
Exploration of correlates of total physical activity and amount of brisk walking led to two 
linear regression models. Motor impairment, physical function, body mass index and 
dyskinesia were significantly associated with total physical activity, explaining 34% of the 
variance, whilst physical function and balance control were significant factors related to brisk 
walking, explaining 22% of variance. Short- and long-term effect analysis revealed that brisk 
walking was the only factor showing a significant interaction effect of group and time. 
Moreover, the effect on brisk walking dissipated 6 months after intervention. Analysis of the 
training effect on physical activity revealed that intervention group affiliation and spring 
season were significantly associated to an increase in brisk walking, while increased balance 
after training was not. 
Conclusion: This thesis provides cut points for physical activity measurement in older adults 
with Parkinson’s disease. Results also suggest that correlates of total physical activity and 
brisk walking differ, and evidence of factors not previously shown to be associated with PA 
in this population, is provided. Moreover, the HiBalance program leads to an increased 
amount of brisk walking in daily living, yet this increase is not linked to improved balance 
control. Also, clinicians should be aware of the seasonal effect on ambulatory activity in this 
population, and that the intervention effect dissipates after half a year, thereby warranting 
recurrent training.  
  
SAMMANFATTNING 
Syfte: Det övergripande syftet med denna avhandling var att undersöka faktorer associerade 
till fysisk aktivitet hos äldre med Parkinsons sjukdom, samt att utvärdera kort- och 
långtidseffekter av HiBalance-programmet på mängd fysisk aktivitet och stillasittande. 
Likaså, att undersöka faktorer kopplade till en träningseffekt på fysisk aktivitet. För detta 
ändamål krävs sjukdomsspecifika estimat av fysisk aktivitet. 
Metod: I det första delarbetet definierades tröskelvärden av accelerometerdata för olika 
gånghastigheter. Trettio äldre med mild till måttlig Parkinsons sjukdom promenerade i tre 
självdefinierade hastigheter av rask, normal och långsam gång, under tre minuter i en korridor 
inomhus. Som referensmått användes gånghastighet och tröskelvärden genererades med 
ROC-kurvor. Tröskelvärdena korsvaliderades samt evaluerades med hjälp av Cohens 
kvadratiskt viktade kappa. I det andra delarbetet undersöktes korrelat till total fysisk aktivitet 
samt tröskelvärdesdefinierad mängd rask gång, via korrelationsanalys följt av multipel linjär 
regression. I det tredje delarbetet användes variansanalys samt en flernivåmodell för att 
undersöka kort- och långtidseffekter av HiBalance-programmet på fysisk aktivitet och 
stillasittande.  Likaså undersöktes associerade faktorer till en träningseffekt via en multipel 
linjär regression. 
Resultat: Optimala tröskelvärden för den vertikala axeln var ≤328 och ≥730 counts per 15 
sekunder för respektive ≤1.0 m/s och >1.3 m/s. Sensitiviteten definierades till 68-100% och 
specificiteten till 75-82% för respektive hastighet, medans validering och Kappa-resultaten 
visade 74% absolut överensstämmelse samt en betydande överenstämmelse på κ = 0.79 (95% 
CI 0.70–0.89) för tröskelvärdena. Undersökningen av faktorer relaterade till total fysisk 
aktivitet och mängden rask gång ledde till två linjära regressionsmodeller. Motorisk 
nedsättning, fysisk funktion, kroppsmasseindex samt dyskinesi var signifikant associerade 
och förklarade 34% av variansen av total fysisk aktivitet, medans fysisk funktion och 
balanskontroll sågs signifikant associera till rask gång, med en förklarad varians på 22%. 
Analysen av kort-och långtidseffekter visade att rask gång var den enda faktor som påvisade 
en signifikant interaktionseffekt mellan grupp och tid. Likaledes, effekten på rask gång 
upphörde sex månader efter träning. Analysen av träningseffekt på fysisk aktivitet visade att 
tillhörighet till träningsgruppen samt sommarhalvåret var signifikant associerat till en ökning 
av rask gång, dock ej en förbättrad balansförmåga. 
Konklusion: Denna avhandling tillhandahåller accelerometertröskelvärden för mätning av 
fysisk aktivitet hos äldre med Parkinsons sjukdom. Övriga resultat visar att korrelat till total 
fysisk aktivitet och rask gång är åtskiljda, dessutom tillhandahålls ny evidens vad gäller 
korrelat till fysisk aktivitet hos denna grupp. Vidare redovisas att HiBalance-programmet 
ökar mängden daglig rask gång hos äldre med Parkinsons sjukdom, dock är denna ökning 
inte kopplad till ökad balansförmåga. Likaså bör kliniker vara medvetna om säsongseffekten 
på mängden rask gång och att effekten av träning upplöses efter ett halvår, vilket föranleder 
återkommande träning.  
  
LIST OF SCIENTIFIC PAPERS 
 
I. Nero H, Benka Wallén M, Franzén E, Ståhle A, Hagströmer M. Accelerometer cut 
points for physical activity assessment of older adults with Parkinson’s disease.  
PLoS ONE. 2015, 10(9): e0135899.doi:10.1371/journal.pone.0135899. 
 
II. Nero H, Benka Wallén M, Franzén E, Conradsson D, Ståhle A, Hagströmer M. 
Objectively assessed physical activity and its association with balance, physical 
function and dyskinesia in Parkinson’s disease. J Parkinsons Dis. 2016 Oct 
19;6(4):833-840. 
 
III. Nero H, Benka Wallén M, Franzén E, Ståhle A, Hagströmer M. Effects of balance 
training on habitual physical activity and sedentary behaviour in older adults with 
Parkinson’s disease. 
In manuscript. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Paper II is reprinted from “Journal of Parkinson’s Disease, Nero H, Benka Wallén M, 
Franzén E, Conradsson D, Ståhle A, Hagströmer M, Objectively assessed physical activity 
and its association with balance, physical function and dyskinesia in Parkinson’s disease, 
Copyright (2016), with permission from IOS Press. The publication is available at IOS Press 
through http://dx.doi.org/[10.3233/JPD-160826]. 
  
  
 
PAPERS RELATED TO THE THESIS 
 
Conradsson D, Löfgren N, Ståhle A, Franzén E. Is highly challenging and 
progressive balance training feasible in older adults with Parkinson's disease? Arch 
Phys Med Rehabil. 2014 May;95(5):1000-3. 
Benka Wallén M, Nero H, Franzén E, Hagströmer M. Comparison of two 
accelerometer filter settings in individuals with Parkinson's disease. Physiol Meas. 
2014 Nov;35(11):2287-96. 
Löfgren N, Lenholm E, Conradsson D, Ståhle A, Franzén E. The Mini-BESTest - a 
clinically reproducible tool for balance evaluations in mild to moderate Parkinson's 
disease? BMC Neurol. 2014 Dec 12;14:235. 
Benka Wallén M, Franzén E, Nero H, Hagströmer M. Levels and patterns of 
physical activity and sedentary behavior in elderly people with mild to moderate 
Parkinson disease. Phys Ther. 2015 Aug;95(8):1135-41. 
Conradsson D, Löfgren N, Nero H, Hagströmer M, Ståhle A, Lökk J, Franzén E. 
The effects of highly challenging balance training in elderly with Parkinson’s 
disease: A randomized controlled trial. Neurorehabil Neural Repair. 2015 
Oct;29(9):827-36. 
Franzén E, Conradsson D, Hagströmer M, and Nilsson M. Depressive symptoms 
associated with concerns about falling in Parkinson's disease. Brain and Behavior. 
2016 Jul; 6: 1–5. 
Conradsson D, Nero H, Löfgren N, Hagströmer M, Franzén E. Monitoring training 
activity during balance exercises: a feasibility study in individuals with Parkinson's 
disease. Undergoing review. 
  
CONTENTS 
1 FOREWORD .................................................................................................................. 1 
2 INTRODUCTION .......................................................................................................... 1 
2.1 Physical activity ..................................................................................................... 1 
2.1.1 General effects of physical activity .......................................................... 2 
2.1.2 Correlates and determinants ...................................................................... 3 
2.1.3 Methods of measurement .......................................................................... 4 
2.1.4 Intervention effects on physical activity ................................................... 6 
2.1.5 Physical activity in adults, older adults and individuals with a 
neurological disease .................................................................................. 7 
2.2 Parkinson’s disease ................................................................................................ 8 
2.2.1 Symptoms, incidence and prevalence....................................................... 8 
2.2.2 Disease progression ................................................................................... 9 
2.2.3 Balance impairments in Parkinsons disease ............................................. 9 
2.2.4 Balance training ...................................................................................... 10 
2.2.5 Hypothetical effects of balance training on physical activity ................ 10 
2.3 Physical activity in Parkinson’s disease ............................................................. 11 
2.4 Rationale for this thesis ....................................................................................... 14 
3 AIMS ............................................................................................................................. 15 
3.1 Specific aims........................................................................................................ 15 
4 METHODS .................................................................................................................... 16 
4.1 Study design ........................................................................................................ 16 
4.2 Ethical approval ................................................................................................... 16 
4.3 Participants .......................................................................................................... 16 
4.3.1 Recruitment ............................................................................................. 16 
4.3.2 Sample size estimation ............................................................................ 17 
4.3.3 Paper I sample ......................................................................................... 18 
4.3.4 Paper II and III sample ............................................................................ 18 
4.4 Data collection ..................................................................................................... 20 
4.4.1 Physical activity measurement ............................................................... 20 
4.4.2 The Unified Parkinson’s Disease Rating scale ...................................... 21 
4.4.3 Balance control ........................................................................................ 22 
4.4.4 Gait .......................................................................................................... 22 
4.4.5 Physical function ..................................................................................... 22 
4.4.6 Dyskinesia ............................................................................................... 23 
4.4.7 Falling ...................................................................................................... 23 
4.4.8 Depression ............................................................................................... 23 
4.4.9 Concerns about falling ............................................................................ 23 
4.4.10 Freezing of gait........................................................................................ 24 
4.5 Procedures ........................................................................................................... 24 
4.5.1 Paper I ...................................................................................................... 24 
4.5.2 Paper II and Paper III .............................................................................. 24 
  
4.6 Intervention .......................................................................................................... 25 
4.6.1 Control group .......................................................................................... 26 
4.7 Data analysis ........................................................................................................ 27 
4.7.1 Paper I ...................................................................................................... 28 
4.7.2 Paper II .................................................................................................... 28 
4.7.3 Paper III ................................................................................................... 29 
5 RESULTS ...................................................................................................................... 30 
5.1 Calibration of the GT3X+ on older adults with pd............................................. 30 
5.2 Factors associated to physical activity at baseline and effects of 
intervention .......................................................................................................... 34 
6 DISCUSSION ............................................................................................................... 38 
6.1 Overall findings ................................................................................................... 38 
6.2 Generated cut points for physical activity measurement.................................... 38 
6.3 Correlates of physical activty in Parkinson’s disease ......................................... 40 
6.3.1 Body Mass Index ..................................................................................... 40 
6.3.2 Disease duration ...................................................................................... 40 
6.3.3 Depression and its measure ..................................................................... 41 
6.3.4 Sleep and accelerometry ......................................................................... 42 
6.4 Effects of balance training on physical activity .................................................. 42 
6.4.1 Effects on brisk walking ......................................................................... 42 
6.4.2 Balance training and physical activity .................................................... 43 
6.5 Methodological considerations ........................................................................... 44 
6.5.1 Internal validity ....................................................................................... 44 
6.5.2 External validity ...................................................................................... 46 
6.6 Implications for clinical practice ......................................................................... 48 
6.7 Future research .................................................................................................... 49 
7 CONCLUSIONS ........................................................................................................... 50 
8 ACKNOWLEDGEMENTS .......................................................................................... 51 
9 REFERENCES .............................................................................................................. 54 
 
  
  
LIST OF ABBREVIATIONS 
ADL 
ANOVA 
AUC 
BETA-PD 
BMI 
H&Y 
MET 
MMSE 
MVPA 
PA 
PAP 
PD 
Activities of daily living 
Analysis of variance 
Area under the curve 
Balance, Elderly, Training, Activity in Parkinson’s Disease 
Body mass index 
Hoehn & Yahr 
Metabolic equivalent of task 
Mini-mental state examination 
Moderate-to-vigorous physical activity 
Physical activity 
Physical activity on prescription 
Parkinson’s disease 
RCT 
ROC 
SD 
TAC 
VM 
 
Randomized controlled trial 
Receiver operating characteristic 
Standard deviation 
Total activity counts 
Vector magnitude 
 
 
 1 
 
1 FOREWORD 
The importance of physical activity (PA) to people of all ages and backgrounds are 
nowadays regarded as more or less common knowledge. Due to its relevance to optimal 
health, it should be in all clinicians’, trainers’ and health professionals’ interest to measure 
the extent of this behavior in their clients/patients. Many instruments have been developed, 
with more emerging, to capture this important behaviour. My idea of a great instrument is 
one that requires minimal amount of technical expertise from the end user, while being as 
exact as possible in its portrait of daily movement. As such, whilst working on this thesis I 
wanted to assist in the refinement of PA quantification using a commonly utilized 
accelerometer, for PA-measurement in older adults with Parkinson’s disease (PD). Also, 
since PA is a behavior so strongly linked to health, and balance disturbances can be a major 
obstacle for people with PD to be active1, I wanted to explore whether an intervention 
aimed at increasing balance performance could also yield secondary effects on PA. 
Hopefully the results presented here can aid clinicians in getting results of interest with 
maximum ease, as well as helping in the ongoing health care implementation of the 
intervention, in order for the person with PD to benefit. 
2 INTRODUCTION 
This thesis and the containing papers is part of a randomized controlled trial (RCT), 
conceptualised under the acronym BETA-PD (Balance, Elderly, Training and Activity in 
PD) project. Within this RCT, the primary aim was to test the HiBalance program on older 
adults with PD and specifically evaluate its effects on balance performance, gait velocity, 
fear of falling and PA (Step 2 in Figure 1). 
 
Figure 1. A graphical overview, including a time line, of the steps in the BETA-PD study. 
 
2.1 PHYSICAL ACTIVITY 
In a well-cited publication by Caspersen et al (1985), the terms PA, exercise and physical 
fitness were differentiated and defined, and PA was defined as any bodily movement 
produced by skeletal muscles that result in energy expenditure. Exercise on the other hand, 
was defined as a sub-category of PA that is planned, structured, repetitive, and has a final or 
STEP 1 STEP 2 STEP 3
Method development
Laboratory studies
Efficacy of the 
HiBalance program in 
a hospital research 
setting
Effectiveness / 
implementation of
the program in 
clinical settings
Year 2011 - 2014 2011 - 2015 2015 - 2018
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intermediate objective of improving or maintaining physical fitness. In this context, 
physical fitness is described as a set of characteristics that are either linked to health or 
skill, and relates to the ability to perform PA2. Different contexts or domains of the behavior 
are also of interest in the PA field of research, such as recreation, transportation, household 
chores, and/or occupation. As such, activity in any of these domains can be health-
beneficial and is therefore officially recommended3. 
To study PA, one may use different dimensions to facilitate the description of the behavior. 
A common approach is the four part model, consisting of: mode that describes the type of 
activity performed; duration indicating the amount of time activity is performed; frequency 
of performed activity; and intensity of the activity4. Most recommendations or guidelines 
regarding PA for health improvement or disease prevention include a determined 
amount/level/type of each dimension. 
The current thesis employed the above described definitions for each term, since they are 
not only commonly used, but may also be considered intuitive.  
 
2.1.1 General effects of physical activity 
The effects of PA on health (or more specifically the incidence of heart disease) has been 
known since the 1950’s 5, 6.  Since then our knowledge continued to grow concerning the 
evidence of its highly potent ability to prevent and treat a large number of conditions and 
diseases7. Nowadays we know that chronic diseases such as cancer and cardiovascular 
disease, but also obesity, type 2 diabetes, stroke, depression and the risk of premature death 
are related to PA, or the lack thereof 3, 8. Decades of research in areas of epidemiology 
(public health) and physiology has shown that PA has both economic, as well as health 
benefits, and that behavior change in different population groups is possible9. 
Since 1995 recommendations regarding the mode and amount of PA to engage in per day 
for achieving health benefits have been available10, and has thereafter been updated11. The 
current recommendation is 150 minutes of moderate intensity PA per week (interchangeable 
with 75 minutes of vigorous activity) or 500 Metabolic Equivalent of Task (MET)-minutes 
per week (where one MET is equivalent of energy expenditure at rest) in a minimum of 10 
minute bouts7. These recommendations established the dose-response relationship between 
PA and health, where those at the lowest level of activity enjoys the greatest health benefits, 
and that beneficial effects are additive with increased activity. According to a recently 
performed prospective cohort study, the minimum amount of moderate-to-vigorous PA 
(MVPA) per week necessary for a reduction in mortality, and an increased life expectancy, 
is 90 minutes, or 15 minutes per day (14% reduced risk of all cause-mortality and an 
extended life expectancy of 3 years)12. There is no recommendation for maximum threshold 
of activity, although benefits are believed to maximize at 3 to 5 times higher than 
recommended levels13.  
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On the other side of the spectrum we find sedentary behavior, which in recent years has 
been up for debate in both scientific papers and media. This term is separate from the 
concept inactivity, where the latter was defined - in this thesis - as not reaching 
recommended levels of PA14. Since the 90’s, sedentary behavior has been regarded as a 
major risk factor for coronary artery disease and cardiovascular mortality, and in recent 
years also been identified as a risk factor for a wide range of other health outcomes15-18. It 
has even been postulated that sedentary behavior involves some physiological mechanism, 
defining it as unhealthy regardless of whether it displaces other activities or not19. 
Sedentary, although a relatively subjective term, is commonly defined as any waking 
behavior characterised by very little body movement and an expenditure of energy <1.5 
METs20, 21. The definition of the behavior thereby includes activities such as sleeping, lying 
down, sitting and most types of screen-based entertainment.  
Although vastly researched, a lack of consensus continues to persist on whether sedentary 
has a unique detrimental effect on health. Studies suggesting a persistent relationship 
between cardio-metabolic deficits and sedentary have adjusted for PA and subsequently 
reported a unique effect of sedentary on health15, 22. However, Maher et al (2014) claims 
that previous studies often adjust for some sub-measure or specific intensity measure of PA 
and not the total activity spectrum23. This method is considered a limited way of analysis, 
and if total activity is used for adjustment, the original detrimental effect of sedentary 
dissipates, according to the researchers23. Whether sedentary behavior has a unique effect 
on health or not, it is still considered to be linked to incremental all-cause mortality. In 
response to the detrimental independent effect of sedentary, recent findings from a meta-
analysis of pooled data suggest that high levels of moderate intensity activity (60-75 min 
per day) may eradicate the higher risk of death due to a large amount of sitting time24. 
Hence, if a large amount of sedentary per day is unavoidable, e.g. due to occupation 
requiring sitting, extra activity may help. 
 
2.1.2 Correlates and determinants 
Understanding the cause of PA behavior is essential when developing and designing public 
health interventions, as well as interventions for specific sub-populations. Since most 
aetiological PA-studies are cross-sectional in nature, statistical association, but not 
causation, is established25 (Figure 2). Cross-sectional studies result in correlates, while 
determinants are established using longitudinal observational studies or experimental 
ones25, 26. To date there are several studies that explored correlates, as well as determinants, 
of PA in different populations and age groups, but mostly focusing on individual-level 
factors in high-income countries. Although correlates are specific for different domains 
(e.g. occupation, transportation, home-based activities etcetera)27, the most common and 
clearest correlates found to be associated with PA in adults and older adults are health status 
and self-efficacy, with evidence corroborating their status as determinants as well28-30. 
Other correlates found to be relevant are age, sex, motivation and previous PA26, 28, 29, 31.  
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In older adults, self-efficacy, PA-identity, social support, health condition, age and 
depressive symptoms have shown to be associated with PA32-34, yet it seems that barriers 
and motivators may differ between active and inactive older adults35. An ecological model 
describing determinants of PA, incorporating intra- and interpersonal as well as 
environmental factors have been suggested, with each domain containing both modifiable 
and non-modifiable ones26.  
Although determinants may be of greater value for understanding the behavior and 
performing interventions, there are advantages to cross-sectional designs and the resultant 
correlates. They provide evidence of possible mediators for the planning of interventions, 
and may aid in analysing several variables with greater ease, providing evidence for 
improvement of intervention design26. 
 
Figure 2. Schematic illustration of difference between correlates and determinants. 
 
2.1.3 Methods of measurement 
Behavior measurement can be challenging no matter what type of measure is chosen. 
Previously, the most common basic construct of interest when quantifying PA was energy 
expenditure, and with the development of new methods and measurements more 
quantitative and qualitative components have come into focus36. To document duration, 
frequency and intensity of PA necessary for evaluating the prevalence of people meeting PA 
recommendations, examining the effect of PA on specific health parameters, investigating 
dose-response and evaluating interventions, valid and reliable measurements are required37. 
When quantifying PA the choice of measure may be a compromise between accuracy and 
feasibility, and PA-questionnaires could in some contexts be the most feasible alternative, 
compared to interviews or wearable sensors38 (Figure 3). 
Physical
activity
*
Health 
status
Unknown direction
Correlates Determinants
Physical
activity
*
Known direction
Health 
status
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Figure 3. A schematic image of the trade-off between accuracy and feasibility in physical 
activity measurement. 
Measures based on self-report (questionnaires, diaries, logs, recalls) are the most widely 
used when quantifying PA. They may include self- or interview-administered 
questionnaires or diaries and typically facilitates the collection of a vast amount of data 
from big populations39. With the use of self-report as a means of measuring PA comes some 
disadvantages. Social desirability may bias the result, just as cognitive impairment limiting 
the ability to recall, understanding of important terms, and ascertaining frequency, intensity 
and duration of activity may hinder the individual to provide an accurate description of 
his/her PA39-41. Adding on, in a systematic review on the reliability and criterion-related 
validity of PA-questionnaires (both existing and new), results showed that very few 
questionnaires boasted with both great reliability and validity, where the greatest flaw 
seemingly being validity, ranging from a coefficient of r = 0.25 to 0.4137. 
Objective PA measurement tools imply devices such as calorimetry, accelerometers, heart 
rate monitors and pedometers. These types of instruments have helped contribute to the 
understanding of PA as a health-related variable, and perhaps also reduced the human error 
incorporated in reporting and recall bias. Although the obvious advantages of the more 
objective measures, some of these are more costly and intrusive, and most also require 
expertise when utilized42. With time wearable monitors such as accelerometers and 
pedometers are becoming more common in PA research, since they provide a more exact 
measure of physiological or mechanical parameters corresponding to activity, in 
comparison to subjective methods43. Using a wearable sensor, such as an accelerometer 
with internal memory, enables for measurement of total amount, intensity, duration and 
frequency of PA, and for analysis of PA patterns over time43. 
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Accelerometers record raw acceleration data in the unit of gravitation (g) in one or more 
axes (vertical, anteroposterior, lateral), or as a vector of the three axes (vector magnitude, 
VM) at a pre-set sample rate of several times per second (normally 30-100 Hz). The raw 
data is pre-filtered (through a band-pass filter to exclude non-human movement) and 
translated to a generic value or measure, sometimes referred to as counts. Counts are 
defined in a pre-selected epoch, and to interpret counts as a meaningful unit, data thresholds 
are used36. Thresholds, or accelerometer cut points are usually defined in validation or 
calibration studies. Most calibration studies have been performed in an environment that is 
controlled, and with protocols containing walking and/or running on treadmills, or based on 
structured activities. Collateral to this process, some physiological measure - thought of as a 
criterion measure (e.g. consumed oxygen) - is simultaneously collected44. Using statistical / 
mathematical methods, thresholds are then generated based on physiological intensity or 
specific activity. These cut-points, derived from laboratory studies, are often highly 
predictive when intensity is of interest, but have limited validity in a free-living setting45. 
Instead, it has been suggested that since accelerometers capture ambulation quite well, 
intensity could be translated to the biomechanical domain, such as referring a cut-point to a 
specific walking speed44. 
 
2.1.4 Intervention effects on physical activity 
Although the convincing arguments around the benefits of increased PA are abundant, 
difficulties in translating evidence of correlates and determinants into an effective 
intervention continue to persist. To achieve programme maintenance and beneficial health 
effects, extensive knowledge on how to implement, adopt and sustain is essential46. Also, an 
understanding of available interventions is necessary. 
Despite these problems, a meta-analysis has shown that there are effective interventions to 
increase PA, in fact, the included interventions showed an overall moderately large mean 
effect (Pearson correlation coefficient of 0.34). Also, the results reported that independently 
of sample size, the effects were moderated and larger when experimental design containing 
behavior modification was utilized, and the intervention was of short duration47. Adding on, 
papers based on previously performed RCT’s containing either a training intervention or 
prescribed exercise have reported beneficial effects on physical fitness, PA and PA-energy 
expenditure in older adults48-50. The results suggest that fitness may be a key element, or at 
least a facilitating factor that increases habitual PA in this population. In a greater context, 
the results also propose factors to consider when choosing, designing or evaluating 
interventions. 
A different example of intervention to consider is the use of pedometers as an instrument to 
encourage PA in daily living, which has increased in recent years. The instrument’s 
popularity has steadily grown and recent accumulated findings show that using pedometers 
in an intervention is associated with increased PA (about 2000 steps per day) and that its use 
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is linked to health-enhancing advantages such as decreased blood pressure and weight 
reduction. However, the added factor of giving the pedometer user a defined step goal was 
essential, since the absence of it nullified any increase in PA51. This is in line with 
previously reported results, indicating that some form of attempt at behavior modification, 
prescription or activity goal is necessary for successful modification of PA. 
 
2.1.5 PA in adults, older adults and individuals with a neurological disease 
Depending on the choice of method for PA measurement, the conclusions of the activity 
level of adults in general may differ. In a Swedish cohort study consisting of 1114 adults 
measured using accelerometry, 52% accumulated 30 minutes of MVPA per day, but only 
1% achieved this level via bouts of ≥10 minutes52. A recent review of PA levels in older 
adults reported a variation of the population reaching recommended levels, ranging 
between 2.4-82%. The variation was due to different definitions of recommended levels, as 
well as contrasting instruments. Although the level varied, in general older adults were less 
active than reference groups53. 
Many of the health benefits of PA for the general population also apply to people with 
certain health conditions or disorders. Since those afflicted can be at even greater risk of 
health risks associated with a sedentary life, the lack of PA is an even more acute problem 
in these population groups. According to estimations from the USA, levels of PA in 
individuals with disabilities (both physical and cognitive) are much lower, compared to 
those without disability, where an estimated 56%, compared to 36%, respectively, perform 
no leisure-time PA at all7. On the other hand, there is strong evidence suggesting that 
outcomes of mental health, cardiorespiratory- and musculoskeletal health typically increase 
by exercise in people with physical disabilities7. Hence the participation of PA may be 
hindered or at least aggravated due to disability, and the beneficial effects of PA may also 
be lacking, thereby increasing risk of more severe disease and further complications. 
Stroke is one of the leading causes of adult motor dysfunction in the world and leads to the 
most hospitalizations when comparing neurological diseases54. As such, it is imperative to 
prevent and treat this disease with maximum efficiency. Findings suggest that an increased 
level of regular leisure-time PA serves as an important component of primary stroke 
prevention in both men and women55, 56. In post-stroke treatment, physical rehabilitation 
and exercise are first-line intervention strategies, since it may reduce chronic impairment by 
promoting neural organisation and reducing the volume of the infarct57, 58. 
More than 2.5 million individuals are afflicted by multiple sclerosis (MS), a demyelienating 
disease of the nervous system resulting in muscle weakness, fatigue, loss of balance, 
depression and declining cognitive function59. It is estimated that about 78% of people with 
MS are inactive, despite the recommendation of PA as a counter-agent to the disabling 
symptoms. These numbers are not due to a lack of interest in PA among the affected, but 
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rather a lack of knowledge among health-professionals regarding the appropriate and 
evidence-based amount of PA suitable60. The recommendations for people with MS have 
gone from advising no exercise to an evidence-supported stance advocating PA or exercise 
due to its beneficial effect on mobility, fatigue and quality of life61. Other reported 
beneficial effects of exercise include increased muscle strength, aerobic capacity, walking 
and balance62. 
Considering the evidence presented above and the fact that aging of individuals with 
disabilities of neurological character is a reality, it is important to acknowledge that with 
ageing comes the natural increase of sedentary, and it is of outmost importance to prevent 
inactivity as well as promoting PA and rehabilitating the affected through PA or some 
structured exercise intervention adapted to each individual. 
 
2.2 PARKINSON’S DISEASE 
In 1817, James Parkinson first described the patients with the clinical symptoms that would 
later be described with his name. About 100 years later, in 1919, it was discovered that 
patients with PD are deprived of cells in the substantia nigra, and in 1957, the 
neurotransmitter dopamine was discovered by Dr. Carlsson in the beautiful city of Lund, 
southern Sweden63. Since then, the knowledge surrounding the disease and its etiology has 
grown steadily. There are several neurological conditions sharing some clinical 
manifestations, with the focus of idiopathic PD being described and studied in this thesis. 
 
2.2.1 Symptoms, incidence and prevalence 
Idiopathic PD is of a neurodegenerative nature and its pathophysiology is defined by early 
death of dopaminergic neurons in the substantia nigra pars compacta. As a result, the 
deficiency of dopamine leads to the manifestation of what is called parkinsonian 
symptoms64. The clinical manifestations of PD are often described by the four cardinal 
symptoms, with the acronym TRAP: Tremor at rest; Rigidity; Akinesia; and Postural 
instability. However, there are several other common symptoms or manifestations related to 
the disease, both motor and non-motor, including, but not limited, to the following: freezing 
of gait; flexed posture; depression; cognitive decline/dementia; autonomic dysfunction; 
anxiety; and sleep fragmentation/insomnia65. The diagnosis of PD is normally based on 
observed symptoms resembling the cardinal symptoms (TRAP) and/or other visible motor 
manifestation such as shuffling gait, combined with response to Levodopa66.  
The prevalence of PD is one of the highest among the neurodegenerative diseases and 
increases with age, starting at (all per 100 000) 428 for 60 to 69 year olds and continuing up 
to 1087 for 70 to 79 year olds67. The incidence also rises with age and has been reported as 
13.4 per 100 000 person-years if age- and gender adjusted, with a peak in incidence 
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between the ages of 70-79 years68, 69. Males have a higher incidence in all age groups. 
Furthermore, it has been postulated that the amount of diagnosed people will increase 
continually in Europe over the next 15 years70. 
 
2.2.2 Disease progression 
Non-motor symptoms are normally present before onset of the more typical motor 
manifestations, such as rapid eye movement sleep behavior disorder which occurs on 
average 12-14 years before motor symptoms71. Later the progression of disease is portrayed 
by worsening of symptoms related to motor function, usually treated using symptomatic 
therapy64.  Disease severity is clinically classified using the Hoehn & Yahr (H&Y) disease 
scale, where a high level of impairment is coupled with a heightened experience of activity 
limitations72. The scale ranges from one to five, where higher class signifies greater 
impairment (Table 1).  With time, long-term side-effects of treatment appear such as motor 
fluctuations, dyskinesia and psychosis73, as well as axial motor symptoms such as freezing 
of gait, balance dysfunction/postural instability, falls and dysphagia64. 
 
Table 1. The Hoehn & Yahr scale. 
1 Unilateral involvement only usually with minimal or no functional disability 
2 Bilateral or midline involvement without impairment of balance 
3 Bilateral disease: mild to moderate disability with impaired postural reflexes; physically independent 
4 Severely disabling disease; still able to walk or stand unassisted 
5 Confinement to bed or wheelchair unless aided 
 
2.2.3 Balance impairments in PD 
Being active in daily living is important to maintain health, and in people with PD, gait and 
balance impairments that develop over time may hinder activity, thereby having a large 
effect on health related quality of life74, 75. Posture and balance are pillars of the ability to 
walk and stand, and balance (or postural) control has been defined as maintenance of 
equilibrium of the body in relation to the force of gravity under both dynamic and static 
conditions76. A perhaps more advanced interpretation of balance control comes from Horak 
et al (2006), where balance/postural control is defined as a complex skill based on different 
sensorimotor processes interacting dynamically, where the goals of postural behavior 
include orientation and equilibrium of posture77. Balance impairment can be present early 
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in PD, and its association to falls and fear of falling potentially adds to the effect of 
undermining activity and independence78. Roughly, one third of individuals with PD 
develop balance impairment during the first two years after diagnosis76, and the 
manifestations of balance problems in PD is believed to be evident in four domains, namely 
balance during quiet stance, reactive postural adjustments, anticipatory postural adjustments 
and dynamic balance79. Evidently, balance impairment responds poorly to medical or 
surgical treatment, such as Levodopa and deep brain stimulation80. Thus, other treatment 
and rehabilitation options for older adults with PD are of major importance. 
 
2.2.4 Balance training 
There is evidence of the benefits of physical therapy for balance performance, showing 
minimal clinical important changes81. Exercise therapy focusing mainly on components of 
balance impairment, i.e. balance training, show moderate to high effect sizes79. As a matter 
of fact, intervention programs incorporating highly challenging balance exercises 
demonstrate to a greater extent an improved performance of activities related to balance, 
compared to other types of programs. Yet, there is no effect on proportion of fallers82. It has 
been proposed that long term follow-ups of balance training interventions are performed to 
determine the trajectory of change over time, and perhaps also cost-effectiveness, 
preferably using some randomized controlled trial of greater quality and size81, 83. 
 
2.2.5 Hypothetical effects of balance training on physical activity 
The reports of beneficial effects of PA or exercise on balance control in older adults are 
numerable84-88, yet there are fewer investigating the inverse relationship. Currently 
available findings report a short term effect of balance training on habitual PA in older 
adults with osteoporosis and in older adults with PD, where outcomes in both studies were 
based on steps/day89, 90. Suggestions have been made that retaining balance control may 
allow people with PD to stay active in daily living. Since there is evidence of 
training/exercise effects on gait and gait-related activities in PD82, 90, 91, together with results 
showing beneficial effects on depression and cognitive decline3, 8, this may also have 
beneficial fallout on level of habitual PA in older adults with PD. Studies have shown an 
association between greater exercise ability and higher level of habitual PA and greater 
balance control92. Adding on, frequent fallers tend to have a greater amount of limitations 
in activities of daily living (ADL) leading to a lower ability to perform common day-to-day 
activities, and also a greater fear of falling, shown to be associated with lower levels of 
habitual PA93. Therefore, by performing balance exercises it may be possible to increase or 
at the very least retain ones level of daily activity, despite functional limitations. 
Investigations are needed to confirm or reject these assertions, since the relationship 
between balance control and PA may be influenced by mediating factors.  
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2.3 PHYSICAL ACTIVITY IN PD 
Previous research has shown that in general, individuals with PD do not reach the 
recommended amount of PA 94-96. The desirable effects of PA are also available for people 
with PD, as reviews of the literature have concluded beneficial effects on mobility, gait, 
balance and muscle strength97-99. When considering more structured PA, people with PD 
who exercise have higher self-rated mobility and self-efficacy, and are less depressed in 
comparison to those not exercising100. Exercise may also improve the dopaminergic system 
and optimize drug efficiency94. Adding to the discourse, both experimental and basic 
research has shown that high-intensity exercise may promote neuroplasticity in areas of the 
brain affected by PD101-104. Furthermore, the non-motor symptoms related to PD, such as 
depression, sleep disturbance and cognitive decline, may all add to the risk of adopting a 
sedentary lifestyle, which may start a vicious circle, considering that inactivity may 
negatively affect clinical manifestations of the disease94. Hence, sedentary may accumulate 
and increase the risk of comorbidities and mortality (Figure 4). 
 
Figure 4. Symptoms of PD and the vicious circle. Inspired by Speelman et al (2011)94. 
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Most studies investigating activity have used subjective measures, probably due to the ease 
of administration, lower costs or sample sizes that have been of a magnitude that hinders 
objective measurement. However, the tide is turning and objective measurement is 
becoming more common. In a systematic review performed by the author in 2015 
(unpublished) with the aim of gathering articles reporting objectively measured habitual PA 
in older adults with PD, 13 studies were found in the literature. After initial quality control 
and exclusion of those not reaching general recommendations of what constitutes valid 
number of measured days / measurement period and hours / day, as well as those publishing 
more than once on the same cohort, seven papers remained (Table 2). 
  
 
1
3
 
 
Table 2. Studies of objectively measured habitual weekly physical activity in older adults with Parkinson’s Disease, available in the Pubmed, Cochrane 
and Web of Science databases in 2015. 
Paper Quality
a 
Type of measure PD population
b 
Total PA
c
 Health-enhancing PA
d 
Reached recommendations 
(%)
e
 
Benka Wallén et al, 
2015
105
 
High Accelerometer, 
Actigraph 
PD, mild to moderate 293 614 TAC 16.4 min/day 27% 
Dontje et al, 2013
106
 Average Accelerometer, 
TracmorD 
PD, mild to moderate 510 mean 
kcal/day 
17.8 min/day 15% 
Ford et al, 2010
107
 Average Pedometer, StepWatch3 PD, mild to moderate 8996 steps/day - Inconclusive 
Hale et al, 2008
108
 Average Accelerometer, RT3 PD, minimum 6 months since 
diagnosis 
122 094 MVM
f
 - Inconclusive 
Lord et al, 2013
109
 Average Accelerometer, 
ActivPAL 
PD, mild to moderate 5452 steps/day 5,1 min/day 21% 
Rochester et al, 
2012
110
 
High Accelerometer, 
ActivPAL 
PD, advanced 2259 steps/day - Inconclusive 
van Nimwegen et al, 
2013
111
 
High Accelerometer, 
Tracmor(D) 
PD, mild to moderate 458 kcal/day - Inconclusive 
aDefined using a checklist based on Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU) observational study checklist112 and Tooth et al113. 
bDescription of the population from which the sample was drawn. cTotal activity counts (TAC) or steps per day. dMean amount per day. e10 000 steps / day or 30 min of moderate to 
vigorous PA / day. fMean vector magnitude.
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Of these seven, only three reported some measure of MVPA or number of participants 
reaching recommendations. The low number of studies suggests further investigation of 
level of PA in this group. Although no greater conclusion should be drawn from these few 
papers, the results display a population not reaching recommended levels of PA, and in dire 
need of effective interventions. 
 
2.4 RATIONALE FOR THIS THESIS 
Due to the importance of PA for older adults with PD, a need for valid, reliable and 
clinically accessible ways of measuring PA objectively is apparent. Accelerometry is a 
method increasing in popularity, with the Actigraph accelerometer being one of the most 
utilized instruments. Using cut-points to define different levels of activity is a common 
methodology in objective measurement, due to it being an accessible and easy way to 
quantify and analyse free-living PA114. Individuals with PD usually develop gait disorders, 
such as increased inter-stride variability, reduced walking speed with increased cadence, 
decreased step length, and gait hypokinesia that worsens as the disease progresses 115, 116. 
When measuring PA objectively, such as with an accelerometer, an altered gait presumably 
influences the measurement and induces a measurement error if cut points generated from 
healthy adults are used during analysis. This potential error might affect the defined levels 
of time in different activity levels when measurements on individuals with PD are analysed, 
hence modifying conclusions based on the data. Since specific cut-points for PD have been 
lacking, the need for a calibration is essential, in this case of one of the most commonly 
used accelerometers. 
To properly understand a behavior such as PA and design interventions influencing it, it is 
essential to fathom what influences the behavior and find modifiable factors that are 
associated. Associated factors of PA have previously been explored in PD, but the variance 
of PA has only been partly explained, highlighting the need for further exploration of 
correlates95. Adding on, since there is a proposed association with balance control and 
habitual PA and ADL, the effects of a highly-challenging balance training program on PA in 
older adults with PD is of great clinical interest. Mild-to-moderate disease severity is of 
specific interest, since although balance and mobility impairments are apparent, ambulation 
is still independent. If successful in increasing health-enhancing PA through this program, it 
may supplement the arguments for implementation into clinical practice. Also, if long term 
effects are investigated, indications as to how often older adults with PD need to train to 
keep potential effects may become apparent.  
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3 AIMS 
The overall aim of this thesis was to investigate correlates of PA in older adults with PD 
and to evaluate both short and long term effects of the HiBalance program on PA and 
sedentary behavior. A further aim was to investigate the associated factors to a training effect 
on PA. To this end disease-specific physical activity estimates are needed. 
 
3.1 SPECIFIC AIMS 
Paper I: The objective of the study was to define and validate accelerometer cut points for 
both the vertical axis and vector magnitude (VM) for different walking speeds in older 
adults with mild-to-moderate PD. 
Paper II: The aim was to investigate demographic, disease- and mobility-related factors 
that associate with objectively measured PA in a sample of older adults with mild-to-
moderate PD. 
Paper III: This paper aimed to investigate short-and long term effects of the HiBalance 
program on total PA, amount and bouts of brisk walking, and sedentary behavior. A further 
aim was to examine factors associated with a training effect on PA. 
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4 METHODS 
4.1 STUDY DESIGN 
Paper I is a methodological calibration study of the accelerometer of choice, with Paper II 
founded on a cross-sectional study and Paper III describing a randomized controlled trial 
with short- and long-term follow up, evaluating the HiBalance program (the BETA-PD 
study; clinical trial number NCT01417598). 
 
4.2 ETHICAL APPROVAL 
Ethical approval for all studies contained within this thesis was obtained from the Regional 
Board of Ethics in Stockholm (DNR 2006/151-31, 2009/819-32, 2010/1472-32, 2011/37-32 
and 2012/1829-32). These studies were conducted according to the Helsinki Declaration 
(ethical principles for medical research involving human subjects), and all participants 
provided written informed consent before their inclusion. Furthermore, to compensate 
participants in the control group of the RCT for not receiving the intervention during the 
trial, they were offered to take part in the training program after the completion of the 
study. 
 
4.3 PARTICIPANTS 
4.3.1 Recruitment 
In Paper I, participants for the study were recruited using advertisements at the local 
hospital and via patient organisations. The measurements were performed during autumn of 
2013. For Paper II and Paper III, recruitment was performed using advertisements in local 
newspapers and notices at private neurological clinics and local hospitals. A majority of the 
participants (70%) were recruited using advertisements. Data were collected during spring 
2012 to summer 2014.  
Inclusion criteria for the study in Paper I were:  ≥60 years of age; a clinical diagnosis of 
idiopathic PD (Queens Square Brain Bank criteria)117; and mild-to-moderate disease 
severity (H&Y-score 2-3)118. Participants were excluded if a need for any walking 
assistance or aids was apparent or reported or if they were unable to perform nine minutes 
of independently executed walking indoors. 
Eligible participants for the BETA-PD study (Paper II and III) were women and men ≥ 60 
years of age with a clinical diagnosis of PD according to Queens Square Brain Bank 
criteria117 and a H&Y-score of 2-3118. Other criteria were having the ability to ambulate 
indoors without walking aid, impaired balance according to a clinical assessment performed 
at baseline and ≥3 weeks of stable dopaminergic medication. Exclusion criteria were: a 
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Mini-mental state examination (MMSE) score <24119 signifying a cognitive deficit, and 
other medical conditions that would considerably influence balance performance or 
participation in the intervention. Background characteristics of all participants are presented 
in Table 3. 
 
Table 3. Participant characteristics of all included papers in this thesis. 
   Paper I Paper II Paper III
1 
     Training Control 
Descriptive variables   n=30 n=91 n=43 n=40 
Age, years   73 (5) 73 (6) 72 (6) 74 (6) 
Sex – female (%)   13 (43) 39 (43) 16 (37) 20 (50) 
BMI, kg/m²
a 
  24.6 (3) 26 (4) 25 (4) 25 (5) 
PD duration, years   6 (3-9) 5 (2-8) 5 (2-10) 5 (2-8) 
H & Y score (%)      
- 2   15 (50) 39 (43) 20 (47) 15 (38) 
- 3   15 (50) 52 (57) 23 (53) 25 (62) 
LED
b 
  693 (374) 573 (238) 584 (290) 649 (420) 
Balance control
c 
  - 19 (3) 19 (3) 18 (3) 
UPDRS motor
d 
  36 (8) 37 (11) 37 (11) 37 (11) 
UPDRS ADL
e 
  16 (5) 14 (5) 15 (4) 13 (5) 
Characteristics presented as means (SD), median (25th-75th percentile) or frequency (%).1Data from baseline 
assessment. aBody mass index. bLevodopa equivalency dose, mg/day according to Tomlinson et al (2010)120. 
cMini-BESTest total score. dUnified Parkinson’s Disease Rating Scale - part III. eUnified Parkinson’s Disease 
Rating Scale – Activities of Daily Living. 
 
4.3.2 Sample size estimation 
Sample size for the study described in Paper I was based on previous calibration studies 
influenced by its methodological nature and lack of effect from which to base power 
calculation upon. Also, the utilization of a leave-one-out cross-validation enabled all 
participants to remain while still validating the results. Previous comparable studies have 
included between 18 and 38 participants121-124. For Paper II and III, sample size estimation 
was based on a pilot study of the HiBalance program125 as well as similar studies performed 
in this population126, 127. To calculate power (80% at a 2-sided alpha level of 5%) three 
outcome measures were used: the Falls Efficacy Scale (FES-I), Mini-BESTest, and gait 
velocity. The final number of 100 participants in the RCT was determined by estimating a 
15% drop out and correcting for long term follow-up. 
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4.3.3 Paper I sample 
For this methodological study, a total of 31 older adults with PD were assessed for 
inclusion. During testing, one individual was excluded due to sudden illness, hence the 
sample finally contained 30 individuals (13 women). Moreover, one participant did not 
partake in all walking bouts due to fatigue, which led to missing data for this individual. 
 
4.3.4 Paper II and III sample 
For the RCT of the BETA-PD study, a total of 100 included participants were divided into 
two geographic cohorts, based on home address (either north or south due to hospital 
localisation). After initial baseline procedures/testing, the participant was randomized to 
either the intervention- or control group, using sealed opaque envelopes, entailing that both 
tester and participant were blinded. Since the persons acting as testers also served as 
trainers during the intervention, blinding of testers at the time points after baseline was not 
possible. However, trainers never acted as testers for individuals who had been part of the 
intervention group that they led in exercise. Of the 100 included and randomized 
participants, 76 completed the final 12 month follow-up (Figure 5). While this number 
completed the whole study, only 66 participants contributed with PA-data at 12 months, due 
to invalid or missing accelerometer data. 
In Paper II, three participants with baseline accelerometer data from the pilot study were 
added, resulting in a total of 91 participants. Furthermore, in Paper III, participants who 
were excluded from the HiBalance program (n=5) was removed from analysis, hence 
baseline numbers differ between Paper II and III.
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Figure 5. Flow chart of participants in the RCT of the BETA-PD project. 
  
Assessed for eligibility
n=146
Randomized
n=100
Excluded n=46
Did not meet inclusion
criteria
Allocated to training
n=51
Allocated to control
n=49
Cancellations n=0
Analyzed n=47
Cancellations n=1
Analyzed n=44
Cancellations n=4
Analyzed n=41
Analyzed n=39
Cancellations n=2
Analyzed n=39
Analyzed n=37
Drop-outs n=4 
Aggravated
symptoms n=1
Medical issues n=2
Displeased with
allocation n=1
Drop-outs n=4
Aggravated
symptoms n=1
Declined further
participation n=2
Deceased n=1
Drop-outs n=4
Declined further
participation n=3
Medical issues n=1
Total drop-outs
n=12
Post-
intervention
6 months
12 months
Drop-outs n=4
Aggravated
symptoms n=2
Displeased with
training n=1
Family issues
n=1
Drop-outs n=2
Aggravated
symptoms n=1
Declined further
participation n=1
Drop-outs n=6
Declined further
participation n=1
Medical issues n=4
Conflicting
treatment n=1
Total drop-outs
n=12
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4.4 DATA COLLECTION 
A wide variety of assessment tools and measurements were used to gather data for the three 
papers, with analysis focusing on describing the samples as well as measure effects of the 
intervention. A summary of all outcomes and measurements used in the studies can be seen 
in Table 4. 
Table 4. Assessments included in the papers of the thesis. 
Assessments   Paper I Paper II Paper III 
Accelerometers   • • • 
UPDRS motor
1 
  • • • 
UPDRS ADL
2 
  •  • 
Electronic walkway
3 
   • • 
Mini-BESTest    • • 
FES-I
4 
   •  
GDS
5 
   •  
SF-36
6 
   •  
PDQ-39
7 
   •  
FOGQ
8 
  •   
LED
9 
  • • • 
BMI
10 
  • • • 
Self-reported falls    •  
1United Parkinson’s Disease Rating Scale motor score (part III). 2United Parkinson’s Disease Rating Scale – 
Activities of Daily Living. 3GaitRITE mat. 4Falls Efficacy Scale – International. 5Geriatric Depression Scale. 
6Swedish Short Form-36 Health Survey. 7Parkinson’s Disease Questionnaire. 8Freezing of Gait Questionnaire. 
9Levodopa Equivalency Dose (mg/day). 10Body Mass Index (kg/m2). 
 
4.4.1 Physical activity measurement 
Throughout all three studies, PA was measured using the Actigraph GT3X+ (Actigraph, 
Pensacola, FL). The GT3X+ is a small, lightweight accelerometer that registers acceleration 
in a raw format with a dynamic range of +/- 6 G and at a sample rate of 30 – 100 Hz. The 
raw data are defined in the unit of gravity and passes through a band-pass filter to eliminate 
non-human artefacts, or noise. At the moment, the user can choose between two filter 
algorithms, the standard filter or the Low Frequency Extension (LFE) option. The LFE 
increases the sensitivity to very low amplitudes, thereby theoretically increasing the 
possibility to sample movement from populations with slow movement or light steps. After 
data collection, all post-processing of data (filter choice, epoch length etcetera) was 
performed in the appurtenant ActiLife (Actigraph, Pensacola, FL) software. 
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In the studies within this thesis, the accelerometer was worn around the waist, attached to 
an elastic belt. For the weekly measurements in Paper II and III, it was worn by the 
participants for all waking hours and only removed when going to bed or during showers or 
baths. A log sheet where participants noted the time when the accelerometer was applied 
and removed was used for every measurement, and handed to the study coordinator after 
performed measure. It was also asked of the participant to note day and time of any activity 
or sedentary behavior that was not standard every-day occurrences, such as being sedentary 
a whole day due to traveling. At every measurement occasion participants were instructed 
on how to attach, wear and remove the accelerometer and the elastic belt. A brief instruction 
manual was also given to the participant which they could take home. 
Accelerometer data were downloaded using ActiLife and processed with the standard filter 
settings, all according to published recommendations128. For Paper II and III, an epoch of 
15 seconds was used, and non-wear time was defined as ≥90 minutes of consecutive zeroes 
which was subsequently removed from analysis. Spike tolerance (the allowance of small 
intervals of non-zero counts within non-wear time) and small-window length (up- or 
downstream window of consecutive zero-counts) was set to 2 minutes and 30 minutes, 
respectively129. After post-processing in ActiLife was completed, the data were transferred 
to a Microsoft Excel (Microsoft, Washington, US) spreadsheet to enable visual comparison 
of collected data with log sheet. By comparing data with logged time, all data collected 
during non-wear could be removed (e.g during accelerometer transport after wear period). 
Days containing <540 minutes of wear time was flagged and then excluded, and as 
thresholds for a valid measurement period, a minimum of four and maximum of seven days 
was used105, 130-132. Participant data with <4 days were excluded, as well as any days 
exceeding the seventh. 
The result of Paper I led to quantification of the brisk walking speed threshold, which was 
utilized to calculate outcome variables in Paper II and III. The threshold for ≤1.04 m/s was 
used as a lower cut-off for calculating minutes of brisk walking. The primary outcomes in 
Paper II was total PA, defined as total activity counts per day of the vector magnitude 
(TAC), and activity corresponding to minutes of brisk walking per day. The latter was 
defined using the threshold of >328 vertical axis (Y-axis) counts/15 second epoch. For 
Paper III, outcome variables were total PA represented by TAC, minutes of brisk walking, 
bouts of brisk walking, sedentary time and sedentary bouts. Sedentary time was derived 
using cut-point thresholds for older adults from Aguilar-Farías et al (2014)133, and bouts of 
sedentary and brisk walking was defined as any continuous bout lasting within the specific 
threshold for ≥10 minutes134. 
 
4.4.2 The Unified Parkinson’s Disease Rating scale 
The motor part of the Unified Parkinson’s Disease Rating Scale (UPDRS-motor)135, which 
assess common symptoms observed in PD such as rigidity, tremor, bradykinesia, gait and 
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postural stability, was used as an indicator of disease severity. It contains 27 items which 
are summarized as a total score (of 108 points), where a higher score indicates a greater 
degree of severity. It has been thoroughly tested for different types of validity and 
reliability, yielding satisfactory results136. Within the UPDRS-motor is the retropulsion test, 
which is used to assign a Hoehn & Yahr-classification corresponding to the disease severity 
of the patient. Although heavily weighted towards postural instability and therefore not 
encompassing a greater image of symptoms, it is widely used and fulfils some reliability 
and validity criteria72. 
Activities of daily living (ADL) were assessed using the UPDRS-ADL (part II), measuring 
disease related ADL, or motor disability136. It is a questionnaire comprising 13 items and 
may be used either in interview form or by self-report. The items cover questions regarding 
the self-perception of bodily functions, such as speech and swallowing, as well as activities 
like walking and making the bed. In the studies of this thesis, an interviewer recorded the 
self-assessed score on the ordinal scale ranging 0-4.The sub-scores were then summarised 
to a total, where a higher score equals more severe problems. The scale has been proven 
both valid and reliable for individuals with PD137. 
 
4.4.3 Balance control 
To measure balance control the Mini-BESTest was used, a clinical test encompassing 14 
items and covering four theoretical components of balance; postural responses, stability in 
gait, anticipatory postural adjustments and sensory orientation138. Sub-scores are based on a 
three-level ordinal scale from 0 to 2 (0 = unable or requires help, 2= normal), with a 
maximum score of 28. The validity and reliability of the Mini-BESTest have been tested 
and proven to be of acceptable standard for older adults with PD139, 140.  
 
4.4.4 Gait 
The measurement of gait was performed using the electronic walkway GAITRite (CIR 
Systems, Inc., Haverton, PA, USA). The nine meter walkway is equipped with pressure 
sensors and connected to a computer, hence enabling collection and analysis of temporal as 
well as spatial gait parameters, such as gait speed and step and stride length. The GAITRite 
has been determined valid and reliable for the measurement of gait performance in 
individuals with PD141, 142. 
 
4.4.5 Physical function 
For the self-assessed measure of physical function, the sub-score Physical Function (PF) 
from The Swedish Short Form-36 Health Survey (SF-36), as well as the sub-domain 
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Mobility from the Parkinson’s Disease Questionnaire (PDQ-39) were used. Both SF-36 and 
PDQ-39 are self-administered questionnaires and cover eight dimensions of health and 
function. The more PD-specific questionnaire, PDQ-39, envelops areas reported by 
individuals with PD as adversely affected by the disease. An important difference between 
PDQ-39 and SF-36 is the score interpretation, where a lower score of the PDQ-39 indicates 
better perceived health, and vice versa for the SF-36. Furthermore, the two scores each 
contain 10 items related to the own perceived ability to be mobile and active in daily life. 
The SF-36 has been proven valid and reliable across many medical conditions143-145. The 
PDQ-39 is the most used and thoroughly tested scale of health-related quality of life in PD, 
and has been tested in countless cultural settings. It has satisfactory validity and reliability 
and is the current recommended measure for individuals with PD146. 
 
4.4.6 Dyskinesia 
During the UPDRS-motor testing, potential dyskinesia in any part of the body was 
assessed, graded on a five grade scale (5=severe, 0= none), and noted. In Paper II, 
dyskinesia was dichotomized (1= dyskinesia in any part of the body, 0= no dyskinesia) due 
to uneven distribution. 
 
4.4.7 Falling 
During the interview process of the BETA-PD study, the number of falls was 
retrospectively reported by the participant. The fall data variable was dichotomized, where 
≥2 falls during the last 12 months classified the participant as a recurrent faller147. The 
definition of a fall was an unexpected event in which the participant came to rest on the 
ground, floor or a lower level148. 
 
4.4.8 Depression 
The Swedish version of the Geriatric Depression scale (GDS) was used as an assessment of 
depressive symptoms149. The Swedish GDS includes 20 questions with dichotomous 
response options and has previously been used for assessment of older adults with PD150. 
The measure has been deemed a valid and reliable self-rating depression screening scale for 
older adults151, 152. 
 
4.4.9 Concerns about falling 
Concerns about falling were assessed using the Falls Efficacy Scale - International (FES-I), 
a self-administered questionnaire covering the performance of 16 specific in-and outdoor 
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daily activities153. Each item is scored on a scale of one to four of which a total score (16-64 
points) is calculated, with a higher value indicating greater concerns about falling. The 
scale has been shown to hold satisfactory psychometric properties154. 
 
4.4.10 Freezing of gait 
Freezing of gait was assessed using the Swedish version of the Freezing of Gait 
Questionnaire (FOGQ). The FOGQ is administered by the clinician, where the individual 
with PD self-rates the level of FOG experienced in daily living. The scale contains six 
items with five scale steps, which is summed to a total score (higher score equals greater 
symptoms). The validity and reliability of the scale have been tested, indicating adequate 
measurement properties155. 
 
4.5 PROCEDURES 
4.5.1 Paper I 
The assessment and data sampling took place at Karolinska Institutet in Huddinge, Sweden 
and were led by a physiotherapist that was well familiar with the methods. A pre-designed 
protocol was followed where participants were first informed of the study and how data 
would be managed and stored, after which written informed consent was obtained. Weight 
and height were measured using an electronic scale and a stadiometer, followed by an 
interview that was conducted where all questionnaires were completed. Next, tests related 
to disease severity were performed, followed by the participant being fitted with a heart rate 
monitor belt around the chest (underneath clothing) and an accelerometer - attached to an 
elastic belt around the waist. Participants wore regular in-door clothing and shoes. A 
walking trial was performed, where the participants briefly practiced walking at their self-
defined speeds of brisk, normal and slow speeds, as well as estimating their perceived 
exertion on the Borg’s Rating of Perceived Exertion (RPE) scale. Thereafter the test session 
was initiated, where participants walked in an in-door circular hallway for three minutes, at 
the three self-defined speeds. Between each walk the participant rested until the heart rate 
reached pre-walking levels. Before and after each walk, the participant rated the exertion 
using the RPE scale, and the physiotherapist documented the present heart rate. 
 
4.5.2 Paper II and Paper III 
Baseline measures of the included participants were performed in a movement analysis 
laboratory at Karolinska Institutet, Huddinge, Sweden. The testing comprised two parts, 
interviewing and administration of questionnaires, and measurement performed in the 
laboratory. After testing, each participant was allocated to either the intervention or control 
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group, using sealed and numbered opaque envelopes to ensure blinding. Prior to 
randomization which was performed in blocks of four, the participants were required to 
choose geographical cohort (north or south, based on living location). Each cohort had 
separate randomization envelopes. If randomized to enter the intervention group, the 
participant entered the HiBalance program, entailing 10 weeks of highly progressive and 
challenging balance training. At the end of the program (three months later), all participants 
were called for testing. The same procedure of testing was repeated six and 12 months after 
intervention. 
 
4.6 INTERVENTION 
The intervention of the BETA PD study, the HiBalance program, was conducted in groups 
of 4-7 participants. The 10-week program was performed for an hour, three times per week, 
and a minimum of two physiotherapists supervised the training. The program entailed four 
theoretical components of balance and gait: Sensory integration (tasks of walking on 
varying surfaces with or without visual constraint); Anticipatory postural adjustments 
(voluntary arm/leg/trunk movements focusing on movement velocity and amplitude as well 
as transitions of posture); Motor agility (coordination of the whole body during variation of 
gait conditions and reciprocal movements and quick shifts of movement characteristics 
during predictable and unpredictable conditions); and Stability limits (voluntary leaning 
tasks in standing with varying weight shifts in multiple directions using arm and trunk 
movement)156. 
The intervention period was divided into three blocks (A, B and C), in line with the 
progressive nature of the program. Block A (week 1-2) was an introduction period, where 
the participants were introduced to single-task balance exercises of each component of the 
program. In block B (week 3-6), dual-task exercises (combining concurrent cognitive 
and/or motor task whilst performing gait and balance exercise) were introduced to each 
component, further increasing difficulty. Finally, in block C (week 7-10), the amount of 
dual task was intensified and the difficulty level of exercises increased by combining 
different components (Table 5). All supervising physiotherapists were educated regarding 
the program and its inherent components, having the necessary practical application of 
theory. 
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Table 5. Overview of the blocks contained within the HiBalance program. 
Block Week Standing Walking Dual Task  
A 
1 Stability limits Motor agility - 
2 APA
 
Sensory integration - 
B 
3 Stability limits Motor agility C 
4 APA Sensory integration M 
5 Stability limits  Motor agility C 
6 APA Sensory integration M 
C 
7 Stability limits 
C + M 
8 Motor agility 
9 APA 
10 Sensory integration 
Dual task; performing several tasks simultaneously. C= Cognitive dual task (e.g adding counting to exercise). 
M = Motor dual task. Adding a motor task to exercise (e.g. carrying a tray or ball); APA= Anticipatory 
postural adjustments. 
 
Each training session started with a five minute warm up containing basic cardiovascular 
exercises. The warm up was followed by highly-challenging exercises that consisted of 
walking and standing, the distribution depending on current component and block, for 
about 50 minutes (short brakes were included). To end the session, a five minute ‘cool 
down’ was performed, focusing on stretching, breathing and slow movements in sitting. 
To conform to clinical practice, the participants in the intervention group received Physical 
Activity on Prescription (PAP) after the intervention ended. The PAP was attuned to each 
participant’s interests, abilities and needs, and followed-up telephonically after 3 months. 
 
4.6.1 Control group 
The control group participants were instructed to maintain normal activity and daily living, 
and were not restricted in any way to participate in any other rehabilitation or training 
program.  
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4.7 DATA ANALYSIS 
Statistical tests, analysis and compilation of descriptive data were performed using SPSS 
for Windows (SPSS Inc., Chicago, IL, USA) and R (R Core Team (2015), R Foundation for 
Statistical Computing, Vienna, Austria. URL: https://www.R-project.org/). Table 6 lists all 
descriptive statistics and statistical methods used in this thesis. 
 
Table 6. Statistical methods used in the respective studies contained in this thesis. 
 Paper I Paper II Paper III 
Descriptive statistics    
Mean • • • 
Standard deviation • • • 
Median • •  
Frequency • • • 
25th-75th percentile • •  
95% Confidence interval • •  
Min-max  •  
Statistical methods    
Receiver operating characteristic curves •   
Leave-one-out cross-validation •   
Cohen’s Kappa •   
Independent samples T-test  • • 
Mann-Whitney U test  • • 
Spearman’s rank correlation test  •  
Pearson Chi-Square   • 
Multiple linear regression  • • 
Mixed ANOVA   • 
Multilevel model   • 
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4.7.1 Paper I 
Data regarding age, BMI, disease duration, disease severity and amount of medication were 
compiled for descriptive purposes. Since walking speed varied in every walking bout (on a 
group level) regardless of instructed speed, data restructuring were deemed necessary. Data 
was restructured using the 75th percentile of slow walking (1.04 m/s) as the lower threshold 
for normal speed, and the 25th percentile of brisk walking (1.31 m/s) as the higher threshold 
for normal speed. Thereafter Receiver Operating Characteristic (ROC) curves were used on 
restructured data to visualize a curve of the trade-off between sensitivity and specificity in 
each domain, and to determine the most sensitive and specific cut-off for the three walking 
speeds. Here, we used an approach that aims to maximize the specificity of the high 
accelerometer count cut-off (brisk), whereas for the low cut-off (low walking speed) 
sensitivity is maximized. This is a common procedure in calibration studies121, 157-159, and 
was done on the basis that a false positive was considered worse than a false negative when 
it comes to a health-enhancing behaviour (brisk walking), whereas the opposite would 
apply for the low walking speed. Area under the curve (AUC), combined with confidence 
intervals was also calculated and reported. After cut-offs with the most beneficial sensitivity 
and specificity were defined, they were validated using a leave-one-out cross-validation. 
Calculated cut-offs on n-1 participants were tested on the individual left out where the 
predicted walking speed was compared to observed speed, thereby investigating the 
agreement. This was performed for all participants, followed by the calculation of a 
quadratic weighted Cohen’s Kappa160. 
As supplementary analyses for this thesis, descriptive comparisons of both self-defined and 
post-restructured walking speed, as well as absolute agreement and quadratic weighted 
Kappa divided by sex, were derived. 
 
4.7.2 Paper II 
Descriptive data regarding demographic, disease-related and mobility-related factors were 
calculated, and variables from each domain were carried forward to either independent 
samples T-test or Mann-Whitney U-test to investigate differences between the classes if 
dichotomous, or utilized in a Spearman rank correlation test (if continuous) to ascertain 
associations to the two dependent variables, total PA (TAC) and brisk walking (minutes of 
walking >1.0 m/s). Dichotomous variables of near statistical significant differences 
between the categories regarding total PA or brisk walking, as well as those correlations 
with a p-value of <0.25, were inserted in two backwards entry linear regression models 
(one for each dependent variable). Age was controlled for in both models. Residual analysis 
showed heteroscedasticity and outliers, hence both dependent variables were square root 
transformed. No multicollinearity or leverage points were present. 
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Supplementary analysis comprised investigation of association between season and levels 
of PA at baseline, using both parametric and non-parametric testing (only results from t-
tests reported). 
 
4.7.3 Paper III 
Data regarding demographics, disease related factors and factors related to physical 
function were summarized descriptively. A Mixed analysis of variance (ANOVA) was used 
to investigate short term effects of the intervention on total PA, brisk walking and sedentary 
behavior. Inspection of outliers was performed visually using boxplots and by calculating 
studentized residuals. Due to the presence of outliers within total PA and brisk walking, 
these variables were square root transformed before entered into the ANOVAs. To examine 
factors associated with a training effect on PA, T-tests were performed to analyse the 
difference between those increasing versus not increasing PA on the variables previously 
shown to be influenced by the intervention (balance control, step length and speed as well 
as UPDRS-ADL)90 and season post-training. Further analysis was performed using a 
multiple linear regression, where associated factors to a difference in PA, was examined. 
The regression model was controlled for age, increased balance and the interaction term of 
group*season to investigate whether season alone had an effect on PA or was dependent on 
group affiliation. 
The long term effects of the intervention on PA were analysed using a Multilevel model 
(maximum likelihood) approach. The model consisted of four fixed factors (time, group, 
time*group, season) and two random factors (intercept and time) to allow for both a 
random intercept and slope. The repeated covariance type was set to a first-order 
autoregressive (heterogeneous) structure, taking into account the higher correlation between 
measures closer in time compared to those further apart, and that variance was assumed 
heterogeneous. Comparison of model fit between nested models was performed using chi 
square goodness of fit test in order to find the most appropriate model (chi square results 
not reported). 
Supplementary analysis comprised of calculating estimates of effect on brisk walking at 
each time point and the corresponding effect sizes using Cohen´s D as well as Hedges G. 
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5 RESULTS 
In this section, results from the performed studies will be summarized, and some 
supplementary analyses will be presented. For a more detailed description of the results of 
each paper, please see the publications and manuscripts. 
 
5.1 CALIBRATION OF THE GT3X+ ON OLDER ADULTS WITH PD 
The data restructure procedure generated three speed intervals with a total of 88 performed 
bouts across 30 participants. Table 7 illustrates descriptive data of the self-selected and post-
restructured speed intervals.
  
 
3
1
 
 
 
 
Table 7. Descriptive data of walking bouts before and after restructuring. 
 Y-axis counts /15 sec
a 
VM counts / 15 sec
b 
Walking speed (km/h) Heart rate (BPM) Perceived exertion (RPE) 
Self-defined      
Slow 332 ± 210 484 ± 242 3.3 ± 0.6 92 ± 18 12 (9-13) 
Normal 548 ± 237 657 ± 251 4.2 ± 0.6 96 ± 19 13 (11-13) 
Brisk 738 ± 273 847 ± 275 5.1 ± 0.8 104 ± 20 14 (13-15) 
Post-restructuring      
≤1.04 m/s 256 ± 150 427 ± 230 3.2 ± 0.4 89 ± 17 13 (9–13) 
1.05–1.30 m/s 574 ± 144 679 ± 176 4.2 ± 0.3 95 ± 18 13 (11–13) 
≥1.31 m/s 819 ± 217 911 ± 232 5.3 ± 0.5 106 ± 19 13 (13–15) 
All values are mean ± SD, except Perceived exertion which is defined as median (25
th
-75
th
 percentile).
a
Y-axis counts per 15 seconds.
b
Vector magnitude counts per 15 seconds.
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The performed ROC curve analysis generated two cut-points per axis, with a sensitivity of 
100-68% and 89-64% and a specificity of 75-82% and 66-82%, attained for the Y-axis and 
VM, respectively (Figure 6). The leave-one out cross-validation showed an absolute 
agreement of 74% for Y-axis cut-points. Calculated cut-points are presented in Table 8 while 
the results from the quadratic weighted Kappa-analysis are displayed in Table 9. 
 
Figure 6. Examples of ROC curves from cut points for ≤1.04 m/s. I = Y-axis, II = VM. 
 
Table 8. Derived cut points for each walking speed and axis. 
Axis Speed
a 
Sensitivity
b 
Specificity
b 
AUC (95%CI)
c
 Cut-point 
Y
d ≤ 1.04 100 75 0.940 (0.882-0.998) ≤ 328 
 1.05-1.30     
 ≥ 1.31 68 82 0.826 (0.716-0.936) ≥ 730 
VM
e
 ≤ 1.04 89 66 0.816 (0.708-0.923) ≤ 470 
 1.05-1.30     
 ≥ 1.31 64 82 0.784 (0.663-0.905) ≥ 851 
a
Meters / second (m/s). 
b
Percent. 
c
Area under the curve with 95% confidence interval. 
d
Y-axis. 
e
Vector 
magnitude. 
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Table 9. Agreement between cut-point calculated speed and actual walking speed. 
Descriptives Y-axis Vector magnitude 
Kappa
a
 0.792 0.691 
SE
b
 0.049 0.068 
95% CI low
c
 0.697 0.559 
95% CI high
d
 0.888 0.824 
a
Quadratic weighted Cohen’s Kappa coefficient. bStandard error. cLower boundary of 95% confidence interval 
for the Kappa coefficient. 
d
Higher boundary of 95% confidence interval for the Kappa coefficient. 
 
Agreement separated by sex resulted in minor differences, with the largest found between the 
absolute agreement of the vector magnitude cut points. Kappa and absolute agreement are 
displayed in Table 10 below. 
 
Table 10. Agreement of derived cut points stratified by sex. 
Descriptives Women Men 
 Y-axis Vector magnitude Y-axis Vector magnitude 
Absolute agreement, % 74 62 73 67 
Kappa
a
 0.790 0.667 0.787 0.710 
Kappa SE
b
 0.079 0.108 0.066 0.091 
Kappa 95% CI low
c
 0.635 0.456 0.658 0.531 
Kappa 95% CI high
d 0.944 0.878 0.915 0.889 
aQuadratic weighted Cohen’s Kappa coefficient. bStandard error. cLower boundary of 95% confidence interval 
for the Kappa coefficient. 
d
Higher boundary of 95% confidence interval for the Kappa coefficient. 
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5.2 FACTORS ASSOCIATED TO PHYSICAL ACTIVITY AT 
BASELINE AND EFFECTS OF INTERVENTION 
Wear time, total PA and percentage of time in sedentary, illustrated by total numbers as well 
as separated by group for all time points, are presented in Table 11.  Sedentary bouts (≥10 
minutes of sedentary) and bouts of brisk walking (≥10 minutes of activity corresponding to 
brisk walking) spanned from 12-15 bouts per day and 0.51-0.98 bouts per day, respectively, 
over the course of the study. The number of brisk walking minutes for each measurement 
time is presented in Figure 7. 
 
Table 11. Wear time, sedentary and total PA of all participants with valid data, for the entire 
sample and when separated by group, at all time-points.  
Groups Wear time
a 
Sedentary
b 
Total PA
c 
at Baseline 
Total sample (n=83) 828 (80) 75 (8) 286445 (143839) 
-Intervention (n=43) 851 (91) 75 (7) 322094 (114383) 
-Control (n=40) 806 (64) 74 (10) 299528 (159962) 
at Post-intervention 
Total sample (n=74) 825 (87) 73 (8) 303685 (162261) 
-Intervention (n=39) 841 (86) 72 (9) 363102 (175930) 
-Control (n=35) 811 (87) 75 (7) 280490 (139463) 
at 6 month follow-up 
Total sample (n=67) 832 (75) 76 (8) 279150 (129247) 
-Intervention (n=36) 842 (74) 74 (7) 314822 (124716) 
-Control (n=31) 823 (77) 77 (8) 262485 (138947) 
at 12 month follow-up 
Total sample (n=66) 824 (92) 76 (8) 262338 (137232) 
-Intervention (n=34) 844 (84) 75 (8) 320444 (138637) 
-Control (n=32) 804 (97) 76 (9) 252497 (135432) 
All values presented as mean (SD). 
a
In minutes per day.  
b
In percentage of wear time. 
c
In vector 
magnitude counts per day.
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Figure 7. Mean minutes of brisk walking and 95% confidence interval (error bars) for the intervention and control group at all measurement points.
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The primary analysis using t-tests to investigate mean differences, in Paper II, showed that 
those with dyskinesia and with a partner had higher total PA compared to those without 
(p=0.02 and 0.19, respectively), and those with a H&Y-score of 2, compared to 3, had a 
higher number of brisk walking minutes, although insignificant (p=0.22). The correlation 
analysis showed nine and eight variables correlating to total PA and brisk walking, 
respectively. The following analysis using multiple linear regression resulted in adjusted R
2
 
values of 0.34 and 0.22, and gave way to four (and one near significant - balance control, 
p=0.06) and two significant associated factors, of total PA and brisk walking respectively 
(Table 12). 
 
Table 12. Correlates of total PA and brisk walking using multiple linear regression. 
Correlates B Beta p 95% CI for B 
    Lower Upper 
TOTAL PA 
Constant 709.94 - <0.01 224.10 1195.78 
Motor impairment
1 
-3.54 -0.28 <0.01 -5.85 -1.23 
Physical function
2 
1.68 0.24 0.01 0.36 3.00 
BMI
3 
-7.34 -0.24 0.01 -13.00 -1.68 
Dyskinesia
4
 73.04 0.22 0.03 6.00 140.10 
Balance control
5 
7.75 0.19 0.06 -0.31 15.82 
BRISK WALKING 
Constant 1.96 - 0.61 -5.70 9.61 
Physical function
2 
0.04 0.32 <0.01 0.02 0.07 
Balance control
5
 0.19 0.26 0.02 0.04 0.35 
1
UPDRS motor score. 
2
SF-36 Physical function score. 
3
Body Mass Index. 
4
Dichotomized (0=no 
dyskinesia, or 1=dyskinesia). 
5
Mini-BESTest total score. 
 
A difference in absolute numbers between total PA and brisk walking at different seasons of 
the year during baseline was seen, though the distribution was wide and there were no 
significant differences between the seasons regardless of outcome (Figure 8.) 
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Figure 8. Amount of PA at baseline separated by season for total PA and brisk walking. 
 
The ANOVA, investigating short-term effects of the HiBalance program, showed a 
significant interaction effect between group and time for brisk walking (p<0.01), indicating a 
higher amount of brisk walking in the intervention group. All other outcome variables had 
insignificant interaction effects (total PA p=0.21; brisk walking bouts per day p=0.35; 
sedentary per day p=0.19; sedentary bouts per day p=0.53). The examination of factors 
associated with a training effect on PA, using a multiple linear regression showed that the 
emergent difference in brisk walking between baseline and post-intervention was associated 
to group affiliation and season (p<0.01 for both variables), with the association of each one of 
these variables being independent of the other (interaction term season*group p=0.25). 
The long-term effect analysis (Multilevel model) resulted in a significant overall interaction 
term (group*time) for brisk walking (p=0.04), indicating that the intervention group increased 
their amount of brisk walking, in comparison to the control. All other outcomes had 
insignificant interactions (total PA, p=0.43; sedentary time, p=0.27; time in sedentary bouts, 
p=0.36; bouts of brisk walking, p=0.21). Table 13 displays interaction effects between each 
time point for brisk walking, along with respective effect sizes. 
Table 13. Estimates and effect sizes for brisk walking at all time points. 
Parameter Estimate P-value CI 95% 1st effect size
1 
2nd effect size
2 
I-group*PI
a 
10.04 0.04 0.59 - 19.48 0.34 0.34 
I-group*6m
b 
8.23 0.02 1.38 - 15.08 0.36 0.35 
I-group*12m
c 
3.63 0.43 -5.52 - 12.78 0.15 0.15 
1
Effect size calculated using Cohen’s D on mean values and SD for each group and time point. 2Effect 
size calculated using Hedges G. Control group and baseline measures were set as reference categories. 
a
Intervention group*post-intervention. 
b
Intervention group*6 month measure. 
c
Intervention group*12 
month measure. 
Spring Autumn
Total PA - (TAC) per day
279156 TAC
302880 TAC
p=0. 45
Spring Autumn
Brisk walking - minutes per day
p=0.47
28 min
24 min
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6 DISCUSSION 
 
The discussion presented here will cover a few subjects similar to the discussions of the 
papers, yet is more of a speculative nature and will to a greater degree focus on absent results, 
some specific parts of the results in comparison to other studies as well as factors of interest 
that were not explored in this thesis. For further discussion of main findings and methods, 
please see Paper I-III. 
 
6.1 OVERALL FINDINGS 
The results derived from the calibration part of the thesis suggested sensitive, specific and 
cross-validated cut points for both the vertical axis and vector magnitude of the Actigraph 
GT3X+, to be utilized when measuring habitual PA in older adults with PD. According to the 
results, the Y-axis cut points showed greater sensitivity and specificity than that of the VM. 
The investigation of correlates of PA demonstrated that factors associated with total PA and 
brisk walking differs, and that some of these are potentially modifiable, while a consequence 
of medication, such as dyskinesia, may dilute the signal and perhaps also lead to false 
conclusions. Adding on, the evaluation of short-and long-term effects of the HiBalance 
program revealed that PA increased in the intervention, in comparison to the control group, 
yet of all factors investigated, only brisk walking was influenced, with the effect not lasting 
after six months. Further, analysis of factors related to a training effect on brisk walking 
demonstrated that group affiliation and season at the end of the intervention was 
independently associated to an increased PA, while there was no relation to an improvement 
in balance control. 
 
6.2 GENERATED CUT POINTS FOR PA MEASUREMENT 
Although accelerometry is not suitable for all types of human movement, such as weight 
lifting or cycling
161
, the methodology is still suitable for classifying activity intensity of older 
adults, and is even considered a gold standard by some
162
. However, problems incorporated 
in the method arise when aiming to extrapolate and infer some form of physiological or 
functional meaning from gathered data. There are distinct opinions regarding best practice 
when validating or calibrating an accelerometer. On one hand, researchers suggest that if time 
in different intensities of activity is the primary interest, then calorimetry should be used as 
criterion measure
163
. On the other side of the spectrum are those who support a view of 
movement sensors as an instrument measuring a biomechanical aspect of PA, and therefore 
propagate against using a physiological measure as the primary comparison
44
. Also, instead 
of using the more conservative cut point-generating method, it has been argued that pattern 
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recognition is the way forward in the future and should be the first-hand choice, even though 
this methodology is questioned by other researchers due to the limited validity in free-living 
settings
45
. 
Based on the author’s observation of a previously used method where older adults were 
instructed to walk on treadmills whilst being measured using indirect calorimetry (oxygen 
consumption), to assess energy expenditure at different walking speeds, it was decided not to 
use this type of methodology in Paper I. A great number of the observed older adults had 
never used a treadmill before, hence it altered their walking pattern to a great extent, thus 
presumably influencing their physical effort. This was believed a danger to the inherent 
validity, and would perhaps pose an even greater problem in older adults with PD, such they 
already suffer from gait dysfunction and/or balance impairment. Therefore the method of free 
in-door walking was chosen as criterion measure. Nonetheless, the chosen methodology can 
also be questioned. The great gait variability in older adults with PD may influence the effort 
of walking in different speeds, thereby inducing variation in intensity of performed activity. 
Consequently, intensity of each walking speed is harder to establish, and determining 
intensity is the more common approach of calibration studies. 
In the light of these valid arguments against the current methodology, no assumptions of 
these cut-points being related to known PA intensities are made. Other data such as perceived 
exertion and heart rate during walking, were sampled in the study, unfortunately these were 
unreliable measures in our sample due to great variation. If reliable, they could have served as 
criterion measures for intensity. Instead, the generated cut points may serve as a proxy for 
quantifying and separating  health-enhancing behaviours (brisk walking) from behaviours 
associated with poor health (low walking speed)
164, 165
. If physiological intensity of PA is the 
main interest in this population of older adults with a progressive disease, including increased 
debilitation of mobility over time, perhaps some sort of recurrent individual calibration 
should be performed. Such a methodology could increase accuracy, yet would also require 
more resources. 
By utilizing ROC-curves, the optimal cut-points for each walking speed were defined. An 
approach that aims to maximize the specificity of the high threshold (brisk) was used, 
whereas for the low threshold (low walking speed) maximization of sensitivity was chosen. 
This was done on the basis that a false positive was considered worse than a false negative 
when it comes to a health-enhancing behavior (brisk walking), whereas the opposite would 
apply for low walking speed. This type of adjustment of sensitivity and specificity is common 
and has been applied in previous calibration studies
121, 157, 158
, yet it is important to note that 
misclassification cannot be ruled out, since neither the sensitivity nor specificity was 100%. 
Adding on, the use of the leave-one-out cross validation combined with a quadratic weighted 
Kappa is a strength of this calibration study. The resultant sample size matches other 
accelerometer calibration studies fairly well
121-124
, and the chosen type of validation also 
permits all participants to contribute to the data, contrary to other types of cross-validation 
that consume participants to test generated cut points. 
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In Paper II and III the vertical axis cut point >328 counts / 15 sec were used to define brisk 
walking (>1.0 m/s), which ordinarily was the top threshold for the lowest walking speed 
(<1.04 m/s). This was performed to further align the cut point and estimated walking speed to 
the threshold of 1.0 m/s, considering an individual’s self-selected walking speed is indicative 
of functional status
166
, with walking speed <1.0 m/s predicting cognitive decline in 5 years 
and risk of hospitalization in 1 year
167
, while walking >1.0 m/s is associated with greater 
survival in older adults
164
. In point of fact, the threshold of 1.0 m/s has also been used in 
previous studies as a boundary between slow and brisk usual walking speed in older adults
168
. 
 
6.3 CORRELATES OF PA IN PD 
6.3.1 Body Mass Index 
Paper II adds to the body of knowledge concerning associated factors of PA. Some factors, 
such as motor impairment and physical function, had previously been reported as significant 
contributors to the variance of PA
95
, while others constituted more novel findings. BMI and 
its relation to PA had not been investigated in older adults with PD before, although both 
weight and height may be negatively affected by increased disease severity due to weight loss 
and stooped posture
169, 170
, coupling with a decrease in PA. Further, in the overall population, 
overweight  / obesity is associated with lower levels of PA and inactivity
26
, and BMI has 
previously shown to be inversely associated to level of PA in adults, an association that 
strengthens with time
171
. In Paper II, results showed a significant relationship between BMI 
and total PA, interpreted as a decrease in total PA with increased BMI. However, the relation 
to brisk walking was insignificant. In the measure of total PA, all types of habitual activity 
are included, even sedentary, at least in a theoretical sense. As an analysis of other types of 
PA or sedentary was not included in the scope of Paper II, it is unknown whether some of 
the other sub-measures also relate to BMI. Furthermore, it is important to consider that the 
measure of weight and height in the BETA PD-study were performed with clothes and in-
door shoes on, hence the measure may be somewhat inaccurate. 
 
6.3.2 Disease duration 
Due to the debilitating consequences of PD, specifically those relating to activity limitations 
and the fact that the disease progresses over time, a relationship between disease duration and 
PA would seem intuitive. However, this was not confirmed in Paper II, since there was no 
significant correlation between disease duration and total PA, nor brisk walking. This result is 
in line with previous research findings indicating the lack of a correlation between objectively 
measured energy expenditure and time since diagnosis
106
. Potential reasons for the lack of 
relationship may be the chosen method of disease duration measurement in the current thesis, 
and the difficulty associated with procedures for diagnosing PD. In the RCT of the BETA-PD 
study, date of diagnosis by neurologist was mainly based on self-report. Naturally, many 
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factors may influence the time or date of diagnosis, such as when symptoms were first 
acknowledged, how long the patient waited to see a neurologist, etcetera. Also, accurate self-
report of diagnosis is dependent upon memory function, and since most older adults with PD 
will eventually develop cognitive impairment affecting not only executive function but also 
memory
172
, the level of accuracy could be questioned. Even though some participants 
contributed with medical journals reporting date of diagnosis, there may still be a variation of 
disease severity within disease duration, hence complicating the analysis of its association to 
PA. 
 
6.3.3 Depression and its measure 
As with other sub-studies of RCT’s, the available correlates to be analyzed were somewhat 
limited. This naturally hindered inclusion of other factors of interest. A factor evidently 
correlated to the level of PA in adults is depression. Reportedly, depression is linked to 
increased sedentary behavior and inactivity, while it is more common later in life and also 
more prevalent in those with a chronic disease
173, 174
. Depression in PD is thought of as 
having more of a biological basis, rather than an emotional reactive one, and could partly be 
the consequence of loss of dopamine and noradrenaline innervation in limbic structures of the 
brain
175, 176
. As such, depression is a common non-motor symptom of PD, reportedly found in 
about 40% of older adults with PD, in comparison to only 10% in geriatric patients without 
PD
177
. Even though the prevalence can vary between 3-90% in PD, depending on the study, 
the average prevalence is still considered substantial, and is believed to be underdiagnosed
178
. 
In the current thesis, depression was assessed using the Swedish GDS. Although there are 
many alternatives, the GDS is a scale frequently used within studies of depression in PD
150
. 
Yet, it may be insensitive to severe depression and utilizing it in people with PD may be 
complicated due to overlapping of symptoms with the disease itself. Also, its content validity 
can be questioned since there is limited concordance between GDS items and Diagnostic and 
Statistical Manual of Mental Disorders IV (DSM-IV)
179
. Perhaps these potential weaknesses 
are part of the reason for the non-significant correlation to PA (results reported in Paper II), 
and a more encompassing measure of depression is needed to establish an association. Or 
perhaps the results suggest that since accelerometry captures a dimension of movement, the 
types of measurements related to motor skills and ambulatory activity are more closely 
related to objectively assessed PA than self-assessed measurements (questionnaires or 
interviews). In point of fact, a study from 2011 showing a significant relation between PA 
and the GDS score in PD based the results on a subjective measure of PA
100
, whilst another 
performed in 2013, also in PD but utilizing an activity monitor, reported insignificant 
findings
109
. Whatever the reason for the lack of a significant finding between these two 
measures when the opposite is expected, this non-motor symptom is of great clinical 
importance, since it is not only detrimental to overall health and health-enhancing behavior 
such as PA, but also pharmacologically treatable.  
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6.3.4 Sleep and accelerometry 
Another relevant factor of interest in PD is sleep. According to the second stage of the 
pathological process of PD, as interpreted by Braak et al (2003), the pathology advance from 
the olfactory bulb to the lower brainstem, thereby inflicting symptoms of autonomic 
characteristics, as well as sleep disturbance
180
. A majority of persons with PD suffer from 
disturbed sleep, with estimations varying between 74-81%, and disturbances are often seen at 
an early onset of disease
181
. The most common form of insomnia in PD is sleep 
fragmentation, where frequent awakenings during the night are common. It is believed that 
the cause of sleep fragmentation is multifactorial, and could be because of, but not limited to, 
the inability to turn at night, bradykinesia and rigidity, and effects of medication. Therefore, 
treatment is based on targeting the probable cause of the sleep disturbance
182
. 
The availability of accelerometers that are able to quantify sleep has steadily increased the 
last decade. The measure of sleep, when using accelerometers, is based on lack of body 
movement at night
183
. If aiming to measure sleep using an accelerometer, it is recommended 
that a wrist-worn accelerometer is used and that data are collected for several days, during all 
24 hours
184
. The measure of sleep using wrist-worn accelerometers has been validated against 
polysomnography, or other established methods of sleep assessment such as sleep diaries or 
videosomnography. The collection of evidence support that accelerometry is useful in the 
estimation of sleep percentage, total sleep time and wake after sleep onset (WASO)
184
.  
This trail of thought leads to the idea that sleep disturbance, for instance WASO or sleep 
fragmentation, is possible to quantify in older adults with PD. Due to the risk of increased 
participant burden, no sleep diary or other measure of sleep was included in the RCT. Adding 
on, because of the potential interference upper extremity tremors, waist worn accelerometers 
were chosen. Considering that exercise or PA has shown to be beneficial for sleep, in both 
adults and older adults
185-187
, and that evidence also exist for the inverse relationship
188
, this 
association would be interesting to investigate in older adults with PD. In future studies of the 
same population, accelerometric measures of PA, coupled with a sleep diary and instructions 
indicating the wearing of accelerometers 24 hours per day, would enable analysis of 
associations to PA and establish the effect of an intervention and/or associations to other 
potential variables of interest. 
 
6.4 EFFECTS OF BALANCE TRAINING ON PHYSICAL ACTIVITY 
6.4.1 Effects on brisk walking 
The results from the short- and long-term evaluation regarding PA correspond with the 
previous short-term evaluation of the HiBalance program, in the sense that the progressive 
balance training led to an increase in ambulatory activity, while the control group decreased 
their amount of ambulation
90
. Interestingly, in Paper III no significant effect on sedentary 
behavior was observed. The wake hours of the day contain a certain amount of PA of 
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different types and intensities mixed with sedentary, which is more or less fixed, unless sleep 
duration is altered. If the amount of brisk walking is altered due to participation in an 
intervention, naturally some other behavior or activity type must decrease
189
. The results 
herein, reporting non-significant findings for total PA and sedentary, leads to further 
questions surrounding chosen methods. In the current methodology, some other PA variable 
was altered in amount by the intervention but it was missed or left unmeasured, or there were 
small changes in each sub-level of PA and sedentary that separately did not reach 
significance. This could be of great interest since it is not only the type of activity that is 
increased that matters to the overall effect on health, but also what it substitutes. Although 
being out of scope for this thesis, some form of analysis of substitutional effects on 
accelerometer data after intervention would be highly interesting in order to more profoundly 
understand the results. 
Adding on, since PA of a certain intensity and level is thought of as a protectant behavior 
from the undesirable effects of sedentary on health
24
, even if sedentary was not decreased by 
the intervention, the results are hopeful. Yet, it is unknown whether the amount of increase in 
brisk walking is of clinical importance, since at the moment there are no guidelines or 
recommended levels of PA that signifies a minimal clinical difference for older adults with 
PD. For adults in general, pooled results of more than half a million individuals suggest that 
amounts of PA lower than the official recommendation still leads to a decreased risk of 
mortality by 20%
13
, raising hope for RCTs reporting significant yet small effects on PA. 
The results reporting a significant association between season and difference in PA are 
clinically valuable, yet become harder to interpret, when considering that there was no 
significant difference at baseline between those measured during winter season compared to 
summer. This difference could be due to differing outcomes (absolute activity at one specific 
moment compared to a difference between two time points) and/or that the sample of each 
paper are not the same. 
 
6.4.2 Balance training and physical activity 
The potential effect of balance training on PA was anticipated due to previously reported 
benefits, though it was hypothesized – as suggested by previous research – that an increase of 
PA would be due to an increase in balance performance, by allowing the ability to be active 
in daily living
92
. Yet the results from the analysis of training effects show otherwise, i.e. no 
association. Previous investigations of training effects in analogous populations have reported 
beneficial effects on objectively measured level of PA, amount of walking and subjectively 
measured ADL. Two contained follow-up measures of different quantities, and one reported a 
dissipation of effect with time, as in Paper III
111, 190, 191
. Adding on, the two papers 
containing effect size measures reported a Cohen’s D of 0.35 for walking >10 seconds / 
minute after home cueing training, and a Hedges G of 0.40 on self-assessed ADL after an 
intervention described as physical therapy. These levels are in line with what were reported in 
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this thesis. Furthermore, considering that PA was a secondary outcome in our RCT and not 
the main aim of the intervention, the effects on brisk walking are of a respectable magnitude. 
Although interventions between studies differ, the results discussed above suggest that a form 
of repeated, structured and challenging exercise leads to increased habitual PA or an 
increased self-perceived ability to perform ADL. In the current study, the actual mechanism 
of the fallout is unclear (apart from the effect of season which is independent on the 
intervention), yet a probable contributing factor to the observed increase is a continuous and 
progressive challenge to the cardiorespiratory and musculoskeletal system that the HiBalance 
program may entail for a great majority of the participants. The experience of being a trainer 
in the program led to the assumption that many participants were not accustomed to this level 
of exercise several times a week, yet increased fitness over time may have helped in the 
management of exercise as the program progressed. In point of fact, we evaluated training 
progression using accelerometers on a smaller sample of participants (n=10) showing 
significant progression of activity during the HiBalance program (results not yet published). 
This is further confirmed by interviews performed with the participants, where findings 
suggests that participants acknowledged the importance of PA to counter the disease and 
described the program as pushing them to the edge of their capability
192
. 
Concludingly, if feasible, future studies would benefit from continuous measurement of heart 
rate or other measure of exertion during intervention and/or some type of exercise 
progression measurement, as well as cardiorespiratory testing pre- and post-intervention. 
 
6.5 METHODOLOGICAL CONSIDERATIONS 
 
6.5.1 Internal validity 
The level of dopaminergic medication in older adults with PD differs between individuals, 
and the responsiveness of medication may vary over the day, e.g. due to differences in 
disease severity, time of onset or sex
193, 194
. Hence, the reduction of motor symptoms due to 
medication is not constant. In the study described in Paper I, participants’ level of 
medication was descriptively outlined yet not controlled for in any way. Although individuals 
were verbally instructed to medicate as usual, so as to capture their normal state, there may 
have been a variation of walking ability due to testing that took place at different times of the 
day. Albeit this may have affected the generated data and therefore also the cut points, the 
potential effect of this on accelerometer sampling of all walking during a week is difficult to 
fathom. Perhaps it would have been an even greater error to adjust level of medication 
beforehand, since the resultant cut points are intended for all-day measurement over a seven 
day period.  
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The approach of utilizing in-door walking in Paper I may be debatable. When designing the 
study, considerations of using out-door walking was discussed. Still, in-door walking was 
chosen for several reasons. Firstly, a pragmatic approach was that weather would not affect 
the measurement, and considering the study was performed during the autumn/winter of 
2013, the climate could have affected results as well as being a potential hazard for some 
participants, due to increased risk of falling. Secondly, walking out-doors would probably 
include changes in altitude, which would reflect free-living walking out-doors. Yet, this 
would perhaps also have an effect on the participants’ exertion and walking speed, which in 
turn could change their ability to walk at higher speed. Instead, in-door walking was the 
method of choice, since more of the environmental factors could be controlled, such as the 
traffic of people, sudden obstacles, etcetera, thereby allowing a more constant walking speed 
and a steady flow of walking, which helped with the calculation of overall walking speed 
during each bout. 
The level of explained variance of the two regression models in Paper II proposes that there 
are other factors to be considered which were not included or measured in this study. There 
are a limited number of other studies exploring associated factors of PA in PD and where a 
linear regression has been utilized as means of main analysis. Those found in the literature 
report a variance ranging 24-69% of total PA or energy expenditure in PD
95, 106
, and about 
30% of explained variance of PA in persons with ischemic stroke
195
. Although this study 
does not encompass the full spectrum of associated factors for PA in PD, the levels of 
variance reported are in line with previous studies, as well as adding to the body of 
knowledge. 
Although accelerometry is considered by many a preferred tool of PA measurement, is easy 
to use and has high sensitivity for detecting changes in PA (irrespective of cut point 
choice)
196
, some aspects of the methodology are not as well established as other popular 
methods such as direct observation or the use of surveys
197
. As such, a potential obstacle for 
valid measurement is the definition of wear time, where, in the current thesis, it is defined 
using the recommended suggestions from Choi et al (2011)
129
. In general, the cleaning 
process of accelerometer data may lead to the exclusion of participants by classifying them as 
non-wearers, despite wearing the accelerometer. This may lead to bias and less data for 
analysis. One way to combat this is using visual evaluation of wear diaries and data, as in the 
current thesis, which has proven to be a highly valid method of choice
198
. These safety 
measures regarding data may help in securing some internal validity, yet other biases related 
to PA measurement is harder to control for, such as social desirability, signifying that 
participants knew of being monitored, hence increasing activity during the measurement 
period in order to seem more active. 
Using a waist-worn accelerometer leads to problems measuring certain types of activities, 
such as carrying a load, bicycling or swimming. This entails a less exact measure of activity 
during the day, if these activities are commonly performed by the wearer. Yet, the choice of 
walking as the outcome or criterion measure was due to it being the most common PA 
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performed in older adults
199
, and therefore should be the primary behavior of focus. 
Optimally, all behaviors should be measured as exact as possible using one instrument and 
wearing position, yet until this is possible for the overall end-user, the researcher must make a 
choice of what is most interesting to capture. Also, considering that intensity of each walking 
speed is unknown due to the method of choice, and may vary by cause of the heterogeneity of 
the symptoms in the population under study
200
, calculating the number of participants 
reaching recommended levels of MVPA is problematic. 
A threat to internal validity related to the RCT of the BETA-PD and therefore also to Paper 
III was that the test assessors were not blinded to group allocation of participants during 
follow-up measurements, considering that some testers also served as trainers in the 
intervention. Although testers never assessed a person involved in their training group, it may 
still have biased the results of some measures performed during laboratory testing, such as 
balance performance. This shortcoming was avoided with regards to PA measurements, due 
to the use of an objective instrument. Yet, due to the study methodology, participants 
themselves were not blinded with regards to group allocation, which is a common problem in 
exercise interventions. 
 
6.5.2 External validity 
A representative sample is necessary to draw conclusions for the population at large. As 
previously reported, older adults with mild-to-moderate disease severity were included in the 
current studies. The inclusion was also based upon a clinical evaluation of balance 
performance. Further, since participants were recruited using advertising, it is probable that 
those joining the study are primarily persons interested in interventions or research, or those 
not suffering from depressive symptoms influencing their motivation. Adding on, all 
individuals with signs of cognitive deficits were excluded, as well as those using some form 
of walking aid, which further limits generalisation of the sample. Therefore the sample may 
be considered more of a sub-group of older adults with PD, rather than representing the 
overall population. In point of fact, according to previous evidence, participants in clinical 
trials are often healthier and are of higher educational background in comparison to the 
general population
201
. Considering all these arguments, demographic data of the samples 
included herein seem to match other studies performed in Sweden and Europe quite well
202, 
203
. 
Although drop outs may be problematic due to its potential effect on the power of the study, 
according to previously performed drop-out analysis of the RCT of the BETA-PD short-term, 
data were missing at random (results not presented here). The amount of missing 
accelerometer data over the course of the RCT was more or less stable over the time-points, 
varying between 5-8 and 4-9 missing measurements per time point in the intervention and 
control group, respectively. Still, some types of analyse, such as the ANOVA, exclude 
participants if data are missing for one measurement point. One way to handle this is to 
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impute data using e.g. multiple imputation, or a statistical model that is able to handle missing 
data, such as a multilevel model (as in Paper III). This type of analysis allows all participants 
measured to remain included without the need for imputation, thereby contributing to the 
variance as much as possible. Yet, the existence of drop outs is still a problem to the external 
validity of any study, since it may dilute the initial randomization and thereby influence the 
ability to generalise the results to the population at large. 
In Sweden, there is a distinct seasonal difference in climate. Winters are cold, resulting in 
larger number of falls in older adults due to slipping on ice or snow 
204
. The evidence of an 
association of seasonal nature on the training effect on PA may be linked to the older adults’ 
fear of ambulating outdoors during winter, supported by the fact that active elderly in Sweden 
attain injuries outdoors more often during winter
205
. This potential effect of the environment 
on PA may not apply to older adults with PD in other countries or continents with a different 
climate.  
Another probable contextual threat to external validity is that the intervention of the RCT was 
performed in a clinical context (a university hospital), which entailed access to clinically 
experienced trainers and equipment needed to perform such an intervention in an optimal 
manner. Yet the amount of resources available was most likely larger compared to regular 
clinical practice. Due to the RCT being an efficacy trial, it tests whether the intervention can 
have an effect in an ideal surrounding, implicating the problem with generalisation of the 
results to other conditions or environments. To measure the degree of beneficial effect in 
other contexts, an effectiveness trial (or pragmatic trial) is required
206
. 
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6.6 IMPLICATIONS FOR CLINICAL PRACTICE 
 
 The generated cut points allow measurement of habitual walking in different walking 
speeds of patients with PD, in order to assess PA as well as mapping out the 
individuals’ activity patterns. Advisably, the vertical axis cut points should be used, 
due to higher accuracy in comparison to that of the VM. The cut points are easily 
accessible for all users of Actigraph accelerometers in the appurtenant software 
ActiLife.  
 
 The results suggest that physical function is closely related to PA, due to its 
significant association to both total PA and brisk walking. Although the causational 
direction of the association is unknown, the relation between these two modifiable 
factors is promising for clinical practice. 
 
 The reported association of dyskinesia with higher levels of total PA proposes that 
clinicians should be aware of the potential repercussion of this symptom on measured 
PA, and if possible, control for its effect. 
 
 When planning balance training, season at the time of intervention should be 
considered, since completion of training during spring or summer may have a 
beneficial effect on amount of ambulation in free-living. 
 
 The effect of the HiBalance program on the amount of brisk walking dissipates after 
six months. Hence, recurrent exercising is recommended if one is to avoid 
participants returning to their levels before training. 
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6.7 FUTURE RESEARCH 
 
 The  use of accelerometers in PA measurement is increasing in popularity197, and the 
methodology is steadily evolving and being improved. Concurrently, more 
sophisticated and reliable ways of data analysis are being developed, yet these new 
methods seldom reach the end-user. Future studies in this area would benefit from 
closing the gap between methods such as pattern recognition and the clinician needing 
easy access to exact data on patients’ PA. Furthermore, subjective measures of motor 
impairment has flaws and could be improved if coupled with a wearable sensor, 
which add advantages such as continous and objective surveillance of symptoms
207
, 
whilst simultaneously gathering PA data. 
 
 It would be of value if future studies further investigate associated factors to 
objectively measured PA in older adults with PD, proposedly with a focus on socio-
cultural, environmental and behavioral factors that may influence activity. The 
sample’s representativeness should be a top priority. Such an investigation would help 
further in understanding the behavior of PA in this population and lead to findings of 
potential mediators and modifiable factors. 
 
 The short and long term effects on PA are of clinical interest, and although effect 
sizes are moderate, it is unknown whether the increase reaches a minimal clinical 
change, since, to date, no such standard has been postulated. Defining such a cut-off 
would be highly useful for future evaluation of interventions. 
 
 Although an increase in habitual PA is promising, proposedly the next step is to 
investigate and develop interventions and strategies aimed at maintaining this change. 
Recurrent training, or exercise referral as well as exploring which behavioral factors 
need to be targeted, could be potential approaches to establish sustainable changes in 
PA. 
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7 CONCLUSIONS 
This thesis suggests sensitive and specific cut points (available in the appurtenant Actigraph 
software) for objective measurement of habitual PA in older adults with PD to be used in 
either epidemiological studies or as a main outcome measure in clinical trials. Further, results 
of the thesis add to the body of knowledge surrounding correlates of PA in the same 
population, confirming the association with disease severity, as well as suggesting that 
dyskinesia should be controlled for when measuring total PA with accelerometers, in order to 
draw valid conclusions. 
The HiBalance program is a progressive and highly-challenging exercise intervention aimed 
at increasing balance control in older adults with PD. The program shows beneficial effects 
on amount of brisk walking that is maintained over a 6 month period that unfortunately 
dissipates thereafter. This suggests that balance training should be performed regularly to 
maintain the potential effect on health preserving PA. Adding on, the increase in ambulatory 
activity after the intervention is not associated with an improvement in balance performance. 
Instead it seems that the season of training – during spring – has a positive effect on 
ambulatory activity, independent of group affiliation.  
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Thanks for babysitting! 
MISCELLANEOUS 
Andy Field – A huge thanks for writing funny and informative statistical books! They’ve 
been a great help. 
Kimmo Sorjonen – awesome teacher and funny guy. All the statistical help through email is 
greatly appreciated. 
 
Metropolen food court – the only valid reason for leaving the desk late evenings when 
working on the thesis. Promoting health by being situated 10 minutes away, promoting 
obesity by serving excellent fatty foods.  
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